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Myocardial Infarction (MI) is one of the most prevalent and deadliest diseases in the 
United States.  Since the host myocardium becomes irreversibly damaged following MI, 
current research is focused on identification of novel, less invasive, and more effective 
treatment options for patients.  Cellular cardiomyopathy, in which viable cells are 
transplanted into the necrotic tissue, has the potential to regenerate and integrate with the 
host myocardium.  Stem cells, specifically pluripotent stem cells such as embryonic stem 
cells (ESCs) and induced pluripotent stem cells (iPSC), are ideal candidates for this 
procedure because they are pluripotent; however, ESCs must be predifferentiated to avoid 
teratoma formation in vivo.    In this dissertation, our goal was improve upon current 
protocols to direct differentiation of ESCs into cardiomyocytes using an embryoid body 
(EB) model.  We immobilized pro-cardiomyogenic proteins, specifically Sonic Hedgehog 
(SHH) and Bone Morphogenetic Protein 4 (BMP4) to paramagnetic beads and delivered 
them in the interior of the EB.  While lineage commitment was indiscriminate, the 
presence of the beads alone appeared to guide differentiation into cardiomyocytes: there 
 viii 
were significantly more contracting areas in EBs containing beads than in the presence of 
SHH or BMP4.  To take advantage of this result, we immobilized Arginine-Glycine-
Aspartic Acid (RGD) peptides to the beads and magnetized them following incorporation 
into the EB.  Magnetically mediated strain increased the expression of mechanochemical 
markers, and in combination with BMP4 increased the percentage of cardiomyocytes.  
Finally, PEGylated fibrin gels were used to investigate the effect of seeding method and 
fibrinogen concentration on cardiomyocyte behavior and maturation.  Cells seeded on top 
of compliant hydrogels had the most contracting regions compared to stiffer PEGylated 
fibrin gels, whereas cardiomyocytes seeded within the hydrogels could not remodel the 
matrix or maintain contractility.  As an alternative to 3D culture, we seeded 
cardiomyocytes within gel layers, which maintained viability as well as contractile 
activity.  We observed that PEGylated fibrin gels can maintain ESC-derived 
cardiomyocytes; however, the ratio of cardiomyocytes and non-cardiomyocytes should be 
optimized to maintain contractile phenotypes.  Therefore, this dissertation presents novel 
methods to differentiate ESCs into cardiomyocytes, and subsequently promote their 
maturation in vitro, for the treatment of MI. 
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 1 
CHAPTER ONE 
Introduction 
1.1.  INTRODUCTION 
 The overall goal of my research is to develop a tissue engineered construct, which 
uses a combination of cells and biocompatible materials, to treat cardiac disease such as 
myocardial infarction (MI).  MI is one of the most prevalent forms of heart disease, and 
the focus of many studies has been on the discovery of less invasive methods to 
regenerate ischemic tissue damaged as a result of the MI event.  Cardiomyocytes, which 
are the muscle cells that make up the myocardium, become necrotic and cannot 
regenerate following MI (Bergmann et al., 2009).  Consequently, MI can be lethal 
without surgical intervention (Go et al., 2013).   
In order to fully restore myocardial tissue function, there are two conditions that 
must be addressed: (1) identification of a cell population that can adequately repopulate 
the myocardium and (2) a medium to deliver the cells into the heart.   Since millions of 
cells are needed to repair the damaged tissue, stem cells are ideal candidates to generate a 
large population of cardiovascular cells.   Pluripotent stem cells (PSCs), which are stem 
cells that can differentiate into all three germ layers (mesoderm, endoderm, and 
ectoderm), have been under investigation for years due to their potential to differentiate 
into cardiovascular lineages.  The bottleneck for their clinical use is finding the most 
effective regimen to guide differentiation specifically into cardiomyocytes and not other 
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cell types.  Similarly, once the adequate cell source has been identified, the next 
challenge is to determine how to deliver the cells into the myocardium.  This is especially 
important because injected cells are quickly lost from the myocardium following MI 
(Aicher et al., 2003). 
In this project we focused on two specific needs for MI repair: (1) optimization of 
cardiomyocyte differentiation methods from PSCs and (2) development of a tissue 
engineered MI patch using cardiomyocytes and fibrin-based hydrogels.  For the first part, 
our goal was to direct lineage commitment of mouse embryonic stem cells (mESCs) into 
mesoderm using biochemical stimulation or mechanical stimulation (Figure 1.1).  Since 
current differentiation protocols using embryoid body (EB) models are not as efficient as 
2D cell culture, we hypothesized that by delivering proteins into the interior of the EB, 
we could increase the percentage of cells that differentiate into mesoderm.  Similarly, by 
delivering magnetic beads coated with cell adhesion peptides into the EB, we can induce 
strain on the cells via magnetic attraction.  This method, known as mechanical 
stimulation, has also been used to drive differentiation towards cardiovascular lineages 
(Geuss & Suggs, 2013).  Finally, we investigated the effect of fibrinogen concentration 
on the maintenance and maturity of mature cardiomyocytes and ESC-derived 
cardiomyocytes. 
1.2.  ORGANIZATION OF THE DISSERTATION 
This dissertation is divided into six chapters.  In Chapter 2, we describe the 
rationale for why cell therapy using PSCs has the most promise for tissue regeneration 
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following MI.  The background of MI is introduced, as well as the most effective 
strategies currently being utilized.  The most effective methods of ESC differentiation are 
presented, specifically biochemical means, as well as the mechanical stimulation 
regimens that have been used to derive cardiomyocytes from ESCs.  This chapter also 
reviews the biomaterials that have been used to maintain cardiomyocytes for 
development of MI patches. 
In Chapter 3, we describe the use of protein-immobilized beads to increase 
mesodermal commitment of mESCs.  Specifically we investigate the effects of two 
proteins, Bone Morphogenetic Protein 4 (BMP4) and Sonic Hedgehog (SHH), which 
have both been used to either guide cardiomyogenesis or repair damaged myocardial 
tissue, respectively.  As opposed to direct supplementation to cell culture medium, we 
have immobilized these proteins to paramagnetic beads and incorporated the beads into 
the EB interior.   We assess cardiomyogenesis by the expression of lineage specific 
markers, as well as demonstration of functional characteristics of mature cardiomyocytes, 
such as contractile activity and sarcomeric α-actin expression.  The results of this study 
suggested that while immobilizing proteins to beads may increase the percentage of cells 
exposed to the growth factors, the decreased potency of those growth factors when 
immobilized inhibits homogenous differentiation. 
In Chapter 4, we use the paramagnetic beads to deliver mechanical stress to the 
cells, instead of for protein delivery applications.  Beads were coated with Arginine-
Glycine-Aspartic Acid (RGD) peptides, which promote cell attachment, and incorporated 
into the EB as described in Chapter 3.  We observed that by magnetizing the cells with 
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neodymium magnets, we could activate mechanochemical signaling in the ESCs through 
the RGD-integrin interactions.  By adjusting the timing of stimulation onset, we can 
direct differentiation towards specific cell lineages: here, application of stimulation on 
Day 3, in combination with BMP4, increases cardiomyogenesis over controls. 
In Chapter 5, we use fibrin-based hydrogels for cardiomyocyte culture.  
Fibrinogen is conjugated with polyethylene glycol prior to crosslinking with thrombin to 
create a PEGylated fibrin gel.  Changing the initial concentration of fibrinogen altered gel 
stiffness.  Murine HL-1 cardiomyocytes were cultured in 3D and 2D on the hydrogels, 
and contractile activity rate as well as cardiomyocyte-specific marker expression was 
analyzed to assess the potential of the hydrogels as MI patches.  We observed that while 
3D culture inhibited contractile activity, 2D culture maintained contractility at rates 
within the range observed in other studies.  We also performed initial experiments 
forming cell-gel layers, hereby referred to as 2DL culture, and observed that this could be 
an alternative in vitro seeding approach on PEGylated fibrin gels.  Finally, in this chapter 
we describe early data of ESC-derived cardiomyocyte culture on 2D gels using the 
differentiation protocol in Chapter 4. 
In Chapter 6, we present a summary of the findings in this dissertation, as well as 
conclusions and future work. 
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Figure 1.1: Overview of the Dissertation.  Mouse ESCs are differentiated into 
cardiomyocytes using either biochemical stimulation (Chapter 3) or 
mechanical stimulation (Chapter 4).  A tissue engineering approach is used 
to combine cardiomyocytes with PEGylated fibrin gels for potential use as 
an MI patch (Chapter 5).   
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CHAPTER TWO 
Background and Significance 
2.1.  MYOCARDIAL INFARCTION AND THERAPEUTIC STRATEGIES 
Cardiovascular disease remains one of the most deadly diseases in America, 
accounting for approximately one of every 6 deaths in 2009 (Roger et al., 2012).  
Myocardial Infarction (MI) is one of the most prevalent manifestations of the disease: in 
2008, 7.9 million Americans experienced MI, of which there were 134,000 deaths (Roger 
et al., 2012). Currently there are five different classifications of MI, which are listed in 
Table 2.1.  The different classifications are predominantly recognized by increased levels 
of cardiac troponin (Tehrani & Seto, 2013; Thygesen, Alpert, Jaffe, Simoons, Chaitman, 
White, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of 
Myocardial Infarction, et al., 2012a), echocardiography, and other biomarkers for 
necrosis.  The most common types are 1 and 2, which typically result from coronary 
artery blockage as a result of artherosclerosis (Figure 2.1).  The loss of oxygenated blood 
flow leads to ischemia, and ultimately cardiomyocyte necrosis which if left untreated can 
be lethal (J. M. Alexander & Bruneau, 2010; M. Chen, Lin, Xie, Wu, & Wang, 2011; 
Duranteau, 1998; Xu et al., 2011). Currently, the most effective treatment strategies 
include fibrinolytic agents, percutaneous interventions, bypass grafting and heart 
transplantation; however, these treatments are not appropriate for all patients, and in the 
case of heart transplant is limited by supply (Pandur, 2005). 
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2.2.  CELL THERAPY FOR MI 
Terminally differentiated cells generally have limited regeneration potential, and 
this is especially true in tissues exposed to low perfusion or oxygen availability.  As an 
alternative to more invasive treatment options, cell therapy, in which an exogenous cell 
population is injected into damaged tissue, can potentially repopulate the infarcted area.  
A challenge surrounding this treatment option is identification of a suitable cell source: 
millions of differentiated cardiomyocytes are needed to successfully replenish the 
damaged myocardium.  Cardiac progenitor cells (CPCs) have been identified as a 
promising cell source as they have exhibited the greatest potential to differentiate into 
cardiomyocytes; however, scale-up of this population continues to be a limiting factor for 
their use clinically (Lyngbaek, Schneider, Hansen, & Sheikh, 2007).   
Stem cells, which have the unique ability to self-renew and differentiate into 
multiple cells types, have also been explored as a cell source for their potential yield.  
Bone marrow stromal cells (MSCs) are multipotent stem cells that readily differentiate 
into osteoblasts, chondrocytes and adipocytes.  There has also been evidence that these 
cells can differentiate into vascular fates, including cardiomyocytes, by supplementing 
the medium with 5-Azacytidine in vitro (Makino et al., 1999; X. Wang & Ha, 2013).  In 
vivo, injection of MSCs into the myocardium of Lewis rats following ligation of the left 
anterior descending coronary artery (LAD) significantly decreased fibrosis and improved 
viability (Berry et al., 2006).  Similar findings were also observed in rabbit models, in 
which significant improvements in vascular density were observed (M. Y. Tan et al., 
2009); however, these results are most likely attributed to decreases in scar tissue other 
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than differentiation into cardiomyocytes, since few injected cells display cardiomyocyte-
specific markers.  Ultimately, for cell transplantation to be successful, cells must be able 
to integrate fully into the host tissue and electromechanically couple with native 
cardiomyocytes (Pandur, 2005; Ye, Zhou, Cai, & Tan, 2011). 
2.3.  EMBRYONIC STEM CELLS AS A SOURCE OF CARDIOMYOCYTES 
As an alternative to adult stem cells, embryonic stem cells are pluripotent cells 
derived from the inner cell mass of the blastocyst.  These cells are unique in that they can 
both self-renew as well as differentiate into all three germ layers, the endoderm, ectoderm 
and mesoderm (Martin, 1981). For this reason not only can ESCs differentiate 
specifically into cardiomyocytes, but they have greater potential to generate a higher 
concentration of cells. 
On the other hand, these cells can become tumorigenic if implanted in vivo 
without pre-differentiation (Kolossov et al., 2006).  To address this, studies have focused 
on optimizing methods to differentiate mouse and human ESCs and iPSCs into 
cardiomyocytes in vitro.  Differentiation efficiency of ESCs into cardiomyocytes is 
evident by the expression of cardiomyocyte-specific genes and protein markers (Figure 
2.2), as well as contractile phenotypes.  Effective differentiation in vitro is demonstrated 
by the combined expression of all of these markers.  Strategies have predominately 
involved stage-specific timing of protein supplementation (Yamashita et al., 2000). 
mirroring the factors that are involved in heart development such as Bone Morphogenetic 
Proteins (BMP), Activin, and Wnt inhibitors.  These methods are very effective in 
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monolayer culture, as cardiomyocyte yields of up to 90-95% have been observed 
following this regimen (Lian et al., 2013). Cardiomyocyte differentiation from EB culture 
is significantly lower, averaging only 1-27% yields (Laflamme et al., 2007a; M. Y. Lee et 
al., 2011; Willems et al., 2011) as indicated by gene markers such as cardiomyocyte-
specific gene Myosin Light Chain 6 (Myl6) (C. Williams, Johnson, Robinson, & 
Tranquillo, 2006) and contractile activity (Laflamme, Zbinden, Epstein, & Murry, 2007b; 
M. Y. Lee et al., 2011). These relatively low yields confirm the necessity to improve EB 
differentiation protocols for more high-throughput systems. 
2.4.  CARDIOVASCULAR DEVELOPMENT DURING EMBRYOGENESIS 
The cardiovascular system is one of the first organ systems to develop in the 
embryo.  Cardiac precursor cells can be found before the onset of gastrulation in the 
lateral posterior epiblast in pre-streak embryos (Van Vliet, Wu, Zaffran, & Pucéat, 2012). 
Formation of the mesendoderm, which is determined by Activin and Nodal signaling, is 
the result of ingression of the cells into the primitive streak (PS) (Berge et al., 2008; 
Evans, 2008; Harvey, 2002; Murry & Keller, 2010; Pandur, 2005; Ye et al., 2011).  
BMP2 signaling plays an important role in reprogramming the mesendoderm and 
promoting cardiogenesis (J. M. Alexander & Bruneau, 2010; Sucov, 1998; Van Vliet et 
al., 2012). Around embryonic day 7.5 (E7.5), the primary and secondary heart fields are 
formed and represented by expression of GATA4 and NK2 homeobox 5 (NKX 2.5) 
(Holtzinger, Rosenfeld, & Evans, 2010; Kolossov et al., 2006; D. Kumar, Kamp, & 
LeWinter, 2005).  At E8.0, the linear heart tube forms, ultimately giving rise to the 
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formation of primitive ventricles and atria at E10.5.  By E15, septation results in 
formation of the mature ventricles and atria, as well as formation of the heart valve (Xin, 
Olson, & Bassel-Duby, 2013) which are coordinated by multiple morphogens including 
the Hedgehog family (Astorga & Carlsson, 2007; Byrd et al., 2002; Lavine, Kovacs, & 
Ornitz, 2008; T. Mammoto & Ingber, 2010; Yamashita et al., 2000) and BMPs (Berge et 
al., 2008; Evans, 2008; Murry & Keller, 2010; Pandur, 2005; Tirosh-Finkel et al., 2010; 
Ye et al., 2011).  
2.5.  MECHANICAL FORCES IN DEVELOPMENT 
Fluid forces play a significant role in heart morphogenesis during development.   
In the embryonic zebrafish heart, shear forces produced from blood flow have been 
measured between 2.5 dyn/cm2 at 3.5 days post fertilization (d.p.f) and 75 dyn/cm2 at 4.5 
d.p.f (Hove et al., 2003; Lucitti et al., 2007). In the same study, glass beads were inserted 
into the heart to block blood flow, ultimately interfering with bulbus formation and 
proper heart looping.   These forces are comparable to in vitro data suggesting that forces 
between 8 and 15 dyn/cm2 cause cytoskeletal arrangement and increases in 
cardiovascular gene expression (Davies, Remuzzi, Gordon, Dewey, & Gimbrone, 1986). 
Similar results were also observed in Myosin Light Chain 2a (Mlc2a) null mice, which 
lack expression of myosin specific to the atrium and have defects in vascular remodeling 
(Lucitti et al., 2007). In these mice, when erythrocytes were unable to leave blood 
islands, blood cycling and vessel formation was severely impaired.  These findings 
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provide strong support that mechanical forces play an important role in heart 
morphogenesis. 
2.6.  EFFECT OF MECHANICAL STIMULATION ON EMBRYONIC STEM CELLS 
Upon ESC aggregation into Embryoid Bodies (EBs) following the withdrawal of 
Leukemia Inhibitory Factor (LIF) in mouse ESCs or basic Fibroblast Growth Factor 
(bFGF) in human ESCs, cells quickly lose their pluripotent phenotype, which is indicated 
by the presence of OCT4, NANOG and Stage-Specific Embryonic Antigen-1 (SSEA-1) 
in mouse ESCs, or SSEA-4, Tra-60 and Tra-81 in human ESCs (Figure 2.2) (Bai et al., 
2010; Boheler et al., 2002; J. Cai et al., 2006; Nieden, Cormier, Rancourt, & Kallos, 
2007; Xu, Police, Rao, & Carpenter, 2002). Cells start differentiating into three germ 
layers, marked by the expression of specific gene markers (Figure 2.2) resulting in a 
dynamic, heterogeneous population of cells. Investigation of pluripotent cell response to 
mechanical stress can employ various models, two of which will be discussed here: two-
dimensional culture on tissue culture plastic, or three-dimensional culture in the form of 
EBs.  These models have been used in studying the effects of cell stress, and also bring to 
question how the timing of stimulation onset can specify cell fate. 
Similar to the developing embryo, ESCs sense environmental changes from 
mechanical stimulation through mechanosensitive ion channels, integrins and tyrosine 
kinase receptors (Labouesse, 2011). Current research has observed that the type of 
stimulation as well as the timing can have very different effects on ESC phenotype.  Such 
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effects include both the maintenance of pluripotency as well as guidance of 
differentiation (summarized in Figure 2.3).   
2.6.1.  Guidance of cardiomyocyte differentiation 
2.6.1.1.  Fluid shear stress 
The type of mechanical stress appears to play an important role on the 
determination of cell fate.  This is especially evident by contrasting evidence that 
mechanical stress, such as shear and cyclic strain, drives pluripotent cell differentiation 
into various germ lineages.  In cell culture, fluid shear stress is defined as the frictional 
force that is generated by the movement of fluid along a surface (Adamo & García-
Cardeña, 2011). The effects of shear stress on stem cell differentiation towards vascular 
cell types, specifically endothelial cells, has been well-defined (Adamo & García-
Cardeña, 2011; Ahsan & Nerem, 2010; Masumura, Yamamoto, Shimizu, Obi, & Ando, 
2009; Metallo, Vodyanik, de Pablo, Slukvin, & Palecek, 2008; Nikmanesh, Shi, & 
Tarbell, 2012; Stolberg & McCloskey, 2009).  
There is currently very limited information on how fluid shear can affect 
cardiomyogenesis in vitro, and the majority of these studies focus on mesodermal 
commitment in mouse ESC models.  In one study, mouse ESCs cultured in monolayer in 
the absence of LIF were exposed to 10 dyn/cm2 laminar shear stress for different periods 
of time ranging from 30 minutes to 8 hours (Illi et al., 2005). After 1 hour of exposure, 
expression of mesodermal and cardiomyocyte markers Vascular Endothelial Growth 
Factor 2 (VEGFR-2) and Myocyte Enhancer Factor 2c (Mef2c), respectively, were 
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increased, indicating the potential of shear stress to influence cardiomyogenesis; 
however, assessment of the functional characteristics of these cardiomyocytes was not 
performed.   In a more recent study, mouse ESCs in monolayer exposed to longer 
durations of shear (4 days at 5 dyn/cm2) expressed nearly 2-fold higher levels of 
mesodermal marker T (Wolfe, Leleux, Nerem, & Ahsan, 2012). Thus under the 
appropriate conditions, shear stress has the potential to drive mesodermal commitment in 
ESCs; however, clarification of how mesodermal commitment translates to 
cardiomyogenesis is necessary. 
2.6.1.2.  Cyclic strain 
Similar to fluid shear forces, cyclic strain and stretch have been shown to 
rearrange the actin cytoskeleton.(Zhao et al., 1995) Cyclic stress is exerted upon cells 
using devices such as Flexercell strain units, which are flexible plates that promote cell 
elongation once deformed (Offenberg Sweeney et al., 2004; Riha et al., 2007). The 
current challenge for optimizing cyclic strain systems is to address the following 
parameters: (1) magnitude of strain, (2) timing of strain initiation, and (3) duration of 
strain. 
The concept of using cyclic strain to induce differentiation is based on the 
biological function of cardiomyocytes.  Cell stretching promotes elongation of the cell 
membrane and orientation of actin filaments, which facilitates the connections made 
between cells that are necessary to promote intracellular communication (Salameh et al., 
2010). Cells near vasculature in vivo experience approximately 1 Hz of cyclic strain due 
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to pulsatile blood flow (Keung, Healy, Kumar, & Schaffer, 2009). The optimal amount 
and rate of strain for in vitro culture was contributed in part by a study performed by 
Schmelter et al (2006), in which Day 4 mouse EBs were attached to Flexercell plates and 
exposed to 5, 10 or 20% strain (Schmelter, Ateghang, Helmig, Wartenberg, & Sauer, 
2006). In this study, application of 10% strain significantly increased the generation of 
reactive oxygen species (ROS) as well as beating areas within EBs.   
2.6.1.2.1.  Cyclic strain in monolayer culture 
Cyclic strain has been shown to downregulate gene and protein expression 
associated with the maintenance of pluripotency in monolayer culture.  In one of such 
studies, mouse ESCs monolayers were exposed to 10% cyclic stretch at 0.17Hz showed 
significant decreases in Nanog as well as increases in markers associated with endoderm 
after 2 days of exposure (Horiuchi, Akimoto, Hong, & Ushida, 2012). On the other hand, 
cyclic strain has also been observed to maintain pluripotency in human ESCs.  In one 
study, 10% strain at 30 cycles per minute was applied to human ESCs in monolayer 
culture for 2 days.  This regimen yielded a higher percentage of SSEA-4+ cells (85%), 
and was reversed to 36% SSEA-4+ when the strain was reduced to 8% at 10 cycles/min 
(Saha, Ji, de Pablo, & Palecek, 2006). The same group later reported that when 10% 
strain is applied to Day 1 human ESCs for 7-12 days, 67% of the cell population is OCT-
4+, compared to 21% in cells cultured in the absence of strain (Saha, Ji, de Pablo, & 
Palecek, 2008). Alternatively, shorter periods of strain at Day 1 can promote 
differentiation.  In a recent study, a loss in pluripotency marker expression was observed 
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in human iPSCs following a stretch regimen of 12 cycles per minute for 12 hours at 15% 
strain (Teramura et al., 2012). The latter was concurrent with inhibition of the Protein 
Kinase B (Akt/PKB) signaling cascade and activation of Rho-associated Protein Kinase 
(Rho/ROCK).  These results suggest that extended cyclic strain can maintain 
pluripotency; however, short applications of higher magnitude strain can reverse this 
phenotype. 
2.6.1.2.2.  Cyclic strain in Embryoid Body culture 
While the microenvironment for EBs is more complex than plated ESCs, cell 
differentiation is similarly influenced by strain.   In these mechanical strain systems, 
mouse ESCs are allowed to aggregate into EBs and subsequently attached onto culture 
plates.  In general, the timing of stimulation can have different effects on differentiation.   
In a microfluidic system, Day 9 mouse EBs were exposed to 24 hours of 10% strain at 1 
Hz (Wan, Chung, & Kamm, 2011). Results demonstrated that α-MHC, a marker for 
cardiomyogenesis, was significantly decreased in Day 9 EBs exposed to strain, 
suggesting that stimulation regimens can potentially interfere with cardiomyocyte 
differentiation at later timepoints.   Day 6 mouse EBs exposed to 5-10% cyclic uniaxial 
stretch at 1 Hz, on the other hand, have significantly increased expression of 
cardiomyocyte markers Connexin 43 (CX43) and NKX2.5 (Heo & Lee, 2011). Finally, 
Day 4 human (Tulloch et al., 2011) and mouse EBs (Gwak et al., 2008) exposed to 2-4 
days of 5-10% strain have displayed increased cardiomyocyte gene expression (cardiac 
α-MHC, Gata-4 and Nkx2.5) compared to static controls. Together, these results suggest 
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that in both mouse and human ESCs, earlier EB exposure to cyclic strain is beneficial for 
differentiation into cardiomyocyte phenotypes, while early and prolonged exposure to 
strain promotes pluripotency. 
2.6.1.3.  Magnetically mediated strain 
While fluid shear and cyclic strain are the most common forms of mechanical 
strain, recent data suggests that magnetically mediated strain can also direct cell fate.   
Early studies investigating the cellular effects of this type of strain have employed 
Arginine-Glycine-Aspartic Acid (RGD)-conjugated magnetic beads.  RGD is a cell 
binding sequence in fibronectin which has known interactions with β1 integrin (Meyer et 
al., 2000). When cells are bound to the RGD-magnetic beads, they can be displaced with 
magnets, producing a mechanical stress.  This method was first employed to study 
signaling pathways involved in mechanotransduction (Laboureau, Dubertret, Lebreton-
De Coster, & Coulomb, 2004; Plopper & Ingber, 1993; N. Wang, Butler, & Ingber, 
1993). 
Magnetically mediated strain was first developed by Wang et al, in which RGD-
beads were attached to plated endothelial cells (N. Wang et al., 1993). Exposing the 
beads to a magnetic field imposed a 90o twist, equivalent to a shear stress of 0 to 68 
dyn/cm2 on the cell surface receptors. Manipulating integrins using this controlled stress 
increased expression of cytoskeletal proteins including talin and α-actinin, which are 
important proteins in contractile activity (Plopper & Ingber, 1993; N. Wang et al., 1993). 
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This study provided a foundation for future work to better understand the effects of 
controlled mechanical stress on cells using magnets. 
The Magnetic Twisting Cytometry technique was built upon the technology used 
by Wang et al, allowing for more precise control of mechanical stress.  Developed 
initially to study the effects of integrin twisting on endothelial cells (J. Chen, Fabry, 
Schiffrin, & Wang, 2001), this method has also been used to apply controlled stress to 
mouse ESCs. Following exposure to a twisting torque of 17.5 Pa at 0.3Hz, cells express 
significantly lower levels of OCT-4 over time compared to unstressed controls (Uda et 
al., 2011). While these studies have mostly focused on pluripotency, future work will 
need to specifically examine lineage commitment, and if this type of mechanical stress 
can positively influence cardiomyocyte differentiation.  
2.7.  CELL RESPONSE TO MECHANICAL STRESS 
The mechanism for how stem cells translate external forces to the direction of cell 
fate is still under investigation.  The effect of shear stress has been the most reviewed and 
studied to date (A. Mammoto, Mammoto, & Ingber, 2012; Stolberg & McCloskey, 
2009). Extracellular matrix proteins can function as mediators between environmental 
forces and outside-in signaling.  Heparin sulfate proteoglycans (HSPGs) have been 
observed to play such a role in ESCs (Gasimli, Linhardt, & Dordick, 2012; Stolberg & 
McCloskey, 2009). These adhesion-dependent proteins mediate the effects of multiple 
proteins, such as Fibroblast Growth Factor (FGF) (Toh & Voldman, 2011), Vascular 
Endothelial Growth Factor (VEGF) (Dias et al., 2012), and BMPs (Khan, Nelson, Pan, 
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Gaffney, & Gupta, 2008). The importance of HSPGs in regards to mouse ESCs’ response 
to stress has recently been investigated (Toh & Voldman, 2011). Mouse ESCs exposed to 
shear stress at 1 dyn/cm2 for 72 hours significantly decreased markers Oct4 and Nanog, 
as well as decreasing proliferation, which is a hallmark of differentiation.  These results 
were abrogated upon the addition of sodium chlorate, which inhibits proteoglycan 
sulfation, indicating the importance of ECM proteins for propagating external signals. 
Expressed integrin types change during the course of development and can be 
specific to the differentiated cell type.  During the earliest stages of development, integrin 
subunits α5 and αv bind to laminin and fibronectin (Hayashi et al., 2007). These 
subunits, along with β1 and β5, are important in ESC self-renewal and maintaining the 
pluripotent phenotype (Kalaskar, Downes, Murray, Edgar, & Williams, 2013; S. T. Lee et 
al., 2012; Rowland et al., 2010). As cells differentiate, the integrin profile changes, and 
consequently the cell’s response to extracellular force changes.  The differences in 
profiles have been well reviewed (Prowse, Chong, Gray, & Munro, 2011), especially in 
human ESCs.  In recent work by Singh et al, hiPSCs were observed to have high levels of 
α6β1 integrin, with changes in adhesive properties over the course of differentiation 
(Singh et al., 2013).  Response to mechanical stresses can therefore potentially be tailored 
to drive differentiation towards a desired cell type. 
Redox signaling has also been observed in cells following mechanical 
stimulation.  In this pathway, ROS, including superoxide anion radicals, hydroxyl 
radicals, and hydrogen peroxide, are generated by the membrane-bound enzyme 
complexes nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidases) 
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(Son et al., 2011).  The extent of radical production can have different effects on the cell.  
While higher concentrations of ROS can be toxic and lead to cell death, lower, localized 
levels can lead to cell differentiation or induce other signaling pathways.  Both 
differentiated (Brewer & Shah, 2009; Lehoux, 2006; Offenberg Sweeney et al., 2004) and 
pluripotent (Bartsch et al., 2011; Buggisch et al., 2007; Sauer & Wartenberg, 2005) cells 
have been observed to generate ROS in response to shear or cyclic strain.   
Mouse ESCs exposed to mechanical stress, especially cyclic strain, have been 
observed to produce ROS during cardiomyogenesis (Heo & Lee, 2011; Sauer & 
Wartenberg, 2005; Sauer, Rahimi, Hescheler, & Wartenberg, 2000; Schmelter et al., 
2006);  however, the exact mechanisms for how integrin-induced ROS production guides 
differentiation is still being elucidated.  Using an EB model, Schmelter et al observed that 
10% strain increased NADPH oxidase expression (Nox-4 and Nox-1) as well as cytosolic 
components p22phox, p47phox and p67phox (Schmelter et al., 2006). In the same study, 
ROS induced ERK1/2, JNK and p38 phosphorylation and subsequently Mef2c and Gata4 
gene expression in Day 4 EBs.   In magnetic twisting studies, cyclic AMP (cAMP) and 
Extracellular-Signal-Regulated kinase (ERK) have also been increased by integrin-
mediated cell stress (Chowdhury et al., 2009; Meyer et al., 2000); however, the effect of 
cAMP upregulation by magnetic mediated strain has not yet been assessed in ESCs.  Heo 
et al also observed increases in DCF (5-(and-6)-chloromethyl-2',7'-
dichlorodihydrofluorescein) fluorescence, a fluorescent marker for ROS, in the presence 
of strain, as well as CX43 and NKX 2.5 expression (Heo & Lee, 2011).  Gene expression 
and ROS was decreased in the presence of ROS inhibitor, Vitamin C.  Mechanical strain 
 21 
also activated the Phosphatidylinositol 3-kinase (PI3k/Akt) signaling pathway and β-
catenin translocation into the nucleus.  These pathways have also been implicated in other 
stimulation regimens, such as electrical stimulation, to promote cardiomyocyte 
differentiation from pluripotent cells (Serena et al., 2009). 
While various signaling pathway components have been observed to be involved 
in a mechanical pathway response, exactly how integrins mediate transduction of 
mechanical stimuli to activation of cardiomyogenesis is more complicated.   Possible 
mechanisms for these responses are summarized in Figure 2.4.  Combined results indicate 
that integrins are likely activating ROS production by NADPH oxidases, which 
subsequently activates the ERK and/or PI3k/Akt pathways to decrease Nanog and 
increase cardiomyocyte-specific markers (Hayashi et al., 2007; Heo & Lee, 2011).  
Recently, another group compared mouse ESC response to mechanical strain in the 
presence of LIF.  They observed that Nanog expression decreased when ESCs were 
strained in the absence of LIF; however, with LIF supplementation, Nanog expression 
was maintained.  The latter traditionally occurs via activation of the JAK/STAT and 
PI3k/Akt pathway (Burdon, Smith, & Savatier, 2002; Watanabe et al., 2006).  While 
perhaps appearing to be in conflict, these results may support the theory that ERK can 
destabilize the PI3k/Akt pathway in ESCs during mechanical strain-induced 
differentiation (Lanner & Rossant, 2010; Patwari & Lee, 2008). 
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2.8.  EFFECT OF BIOMATERIALS ON MATURATION OF EMBRYONIC STEM CELL-DERIVED 
CARDIOMYOCYTES 
 While deriving cardiomyocytes from ESCs addresses part of the bottleneck of 
cellular cardiomyoplasty, there is still debate over whether these cells are truly mature, 
differentiated cardiomyocytes that can restore damaged myocardium in vivo.  While there 
are resemblances between ESC-CM and mature cardiomyocytes, such as contractile 
activity and expression of markers such as CX 43, sarcomeric α-actin and cardiac 
troponin, there are still distinct functional differences.  Morphologically, adult 
cardiomyocytes have aligned sarcomeres, multiple nuclei (Robertson, Tran, & George, 
2013), generally lack spontaneous contractile activity (Bistola et al., 2008), and only 
renew at a rate of 1% per year after age 25 (Bergmann et al., 2009). In contrast, ESC-CM 
are mononucleated, have fewer aligned sarcomeres, and have higher proliferation rates 
(Robertson et al., 2013). 
 In addition to mechanical stress, ESC-CM culture on biomaterials has also been 
observed to promote maturity towards adult cardiomyocyte phenotypes.  Often, these 
materials mimic mechanical or biological properties that are present in the myocardium.  
Material stiffness is one of such properties, such that immature neonatal cardiomyocytes 
are more likely to adapt functional mature cardiomyocyte properties, such as sarcomeric 
α-actin alignment and spontaneous contractions, when cultured on materials with elastic 
moduli ranging from 1-11 kPa (Engler et al., 2008; Engler, Sen, Sweeney, & Discher, 
2006).  Similar observations have also been made for ESC differentiation: mesodermal 
commitment is enhanced when hESCs are cultured on synthetic materials (poly(lactic-co-
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glycolic acid)/poly-l-lactic acid) with high elastic moduli ranging from 1.5-6 MPa  
(Zoldan et al., 2011). 
  Along with stiffness, the design of the scaffold can also influence ESC-CM 
maturity.  Both porosity and anisotropic configurations can promote the formation of 
cell-cell connections and alignment, which is critical for electrical pacing in vitro and in 
vivo (Black, Meyers, Weinbaum, Shvelidze, & Tranquillo, 2009; Dar, Shachar, Leor, & 
Cohen, 2002; Gonnerman, Kelkhoff, McGregor, & Harley, 2012; A. W. Smith et al., 
2012).  In addition, matrix remodeling is also an important consideration when choosing 
a material: a balance between degradation rate and matrix deposition by the transplanted 
cells is also important (Luong & Gerecht, 2008). 
 A variety of materials, both synthetic and natural, have been examined for their 
potential in cardiac tissue engineering.  For the former, poly(glycerol) sebacate polymers 
with micropatterned grooves were observed to promote neonatal cardiomyocyte actin 
alignment and contractile activity (Neal et al., 2013). Scaffolds containing naturally 
derived polymers, such as fibrinogen, are also popular for their biocompatibility.  Further 
cross-linking fibrinogen with PEG, producing a PEGylated fibrin gels, can further 
enhance stability in vitro and in vivo (Drinnan, Zhang, Alexander, Pulido, & Suggs, 2010; 
G. Zhang, Wang, Wang, Zhang, & Suggs, 2006).  Encapsulation of neonatal 
cardiomyocytes in 6 mg/ml PEGylated fibrin gels with a shear modulus of approximately 
8 Pa promotes contractile activity compared to stiffer PEGylated fibrin gels (Shapira-
Schweitzer & Seliktar, 2007; Shapira-Schweitzer, Habib, Gepstein, & Seliktar, 2009).  
Chitosan, which is a derivative of chitin with controllable degradation products, in 
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combination with fibrinogen, promotes improved neonatal cardiomyocyte contractility 
(Blan & Birla, 2008).   
 Finally, matrices can enhance cell retention in the myocardium to further promote 
regeneration and coupling of transplanted cells with the host tissue.  By embedding 
myoblasts within injectable fibrin gels, cells can still be detected in the infarct 24 hours 
following transplantation, subsequently decreases the size of the infarct and restoring 
function (Christman et al., 2004; Ginis et al., 2004; Li & Gao, 2007).  Therefore, the 
“gold-standard” of materials for cardiac tissue engineering must balance all of the 
aforementioned parameters to adequately restore myocardial function. 
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Table 2.1: Types of Myocardial Infarction and Current Treatment Strategies. (Tehrani & 
Seto, 2013; Thygesen, Alpert, Jaffe, Simoons, Chaitman, White, Joint 
ESC/ACCF/AHA/WHF Task Force for the Universal Definition of 
Myocardial Infarction, et al., 2012a) 
Type of Myocardial 
Infarction (MI) 
Cause Treatment 
Type 1: Spontaneous Artherosclerotic coronary artery disease 
Antithrombotic drugs, 
revascularization 
Type 2: Due to ischemic 
imbalance 
Supply-demand imbalance 
in myocardial perfusion 
Blood vessel support or 
control; control of 
tachyarrhythmia; volume 
resuscitation 
Type 3: Sudden cardiac 
death from MI 
Death prior to biomarker 
assessment; have symptoms 
suggesting MI, 
electrocardiographic 
changes 
 
Type 4a: Due to 
percutaneous coronary 
intervention 
Type 4b: Due to stent 
thrombosis 
Type 4c: Due to restenosis 
Must also have other 
symptoms associated with 
MI 
Surgical intervention 
Type 5: After coronary 
artery bypass grafting 
Must also have other 
symptoms associated with 
MI 
Surgical intervention 
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Figure 2.1.  Differentiation between MI Types 1 and 2 according to the condition of the 
coronary artery.  Reprinted with permissions from Thygesen et al, 2012 
(Thygesen, Alpert, Jaffe, Simoons, Chaitman, White, Katus, et al., 2012b). 
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Figure 2.2: Stepwise commitment of Human and Mouse Embryonic Stem Cells using 
Biochemical and Mechanical Cues.  In the absence of LIF, ESCs aggregate 
to form a triploblastic Embryoid Body (EB).  To commit a higher 
percentage of cells toward mesoderm, a combination of BMP4 and Activin 
A is added to the medium.  Inhibition of Wnt in mesodermal progenitor cells 
is also necessary to guide mesoderm progenitors specifically into 
cardiomyocytes (Nieden et al., 2007).  Mechanical stimulation such as fluid 
shear or cyclic stress is typically initiated in Day 4-6 EBs, with a higher 
population of mesodermal progenitors.  Gene (italics) and protein markers 
expressed in human (H) and mouse (M) pluripotent cells at the specific 
stages are indicated. 
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Figure 2.3: Summary of the effects of mechanical stimulation on Pluripotent Stem Cell 
differentiation towards cardiomyocytes.  Boxes indicate the initiation and 
duration of stimulation, followed by the magnitude of stain for murine 
pluripotent stem cells (mPSC) and human pluripotent stem cells (hPSC).  
Arrows depict the observed increases or decreases in markers associated 
with pluripotency (Plu) or cardiomyocytes (CM).  Ref: References. 
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Figure 2.4:  Signaling pathways involved in propagation of mechanical signals from 
cyclic stress.  Application of stress deforms integrins on the cell surface, 
which have been shown to increase Reactive Oxygen Species (ROS) 
production by NADPH oxidase.  ROS increases ERK phosphorylation, 
which inhibits pluripotency gene expression.  Similarly, stress activates the 
PI3k/Akt pathway and translocation of β-catenin into the nucleus, which 
activates cardiomyocyte gene expression.  While integrin activation can also 
increase cAMP expression, its function in ESCs has not been assessed.  
Given the known importance of PI3k/Akt in maintaining pluripotency, it is 
possible that ROS production can inhibit traditional Nanog activation to 
drive differentiation. 
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CHAPTER THREE 
Guiding mouse embryonic stem cell mesodermal commitment with 
paramagnetic beads 
Pluripotent stem cells are ideal candidates for cell therapy due to their potential to 
differentiate into any cell type.  This potential is improved when embryonic stem cells 
(ESCs) are aggregated into embryoid bodies (EBs), further increasing the potential yield 
as the cells can differentiate into all three germ layers and are not limited by surface area.  
This is especially important for treatment of diseases such as heart disease, specifically 
following myocardial infarction, which requires millions of cells to repopulate the injured 
myocardium.  A bottleneck for the use of EBs in cell therapy strategies is that consistency 
is limited by a number of factors including both the size of the EB, as well as 
heterogeneity of the cell population during differentiation.  To uniformly guide 
differentiation, the most effective regimen to date involves the supplementation of growth 
factors or proteins that are known to be important for cardiomyogenesis during 
embryonic development.  In addition, recent research into the gross morphology of the 
EB has demonstrated that a collagen-rich wall forming the endoderm develops around the 
EB three- to four-days after aggregation (Bratt-Leal, Carpenedo, & Mcdevitt, 2009).  
This renders the EB relatively impenetrable to larger molecules and thus cells in the 
interior are not exposed to these proteins, further increasing variation in the cell 
population.  To address this issue, we hypothesized that by immobilizing proteins to 
microbeads and incorporating them into the interior of an EB, we can increase the 
population of cells exposed to pro-mesoderm growth factors and subsequently the yield 
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of cardiomyocytes.  In this study we investigated the effects of two specific proteins, 
Sonic Hedgehog (SHH) and bone morphogenetic protein 4 (BMP4).  We attached SHH 
and BMP4 to paramagnetic beads and incorporated the beads into EBs using Aggrewell 
plates and compared the percentage of EBs with contractile foci in the presence of the 
protein-immobilized beads.  In this chapter, we found that there was little effect of SHH-
immobilized beads on contractile activity due to the decreased potency of tagged SHH.  
The presence of tagged BMP4 also did not appear to affect cardiomyogenesis; however, 
the most significant effect on contractile activity was the result of the presence of the 
beads alone.  This may be the result of an interaction with α1 integrin, as suggested by 
focal adhesion protein microarray. 
3.1. INTRODUCTION 
 The ability of embryonic stem cells to aggregate into embryoid bodies provides an 
opportunity to derive a large population of cells from all germ lineages: ectoderm, 
endoderm, and mesoderm.  This potential addresses a significant need for effective cell 
therapy, in which large concentrations of differentiated cells are used to repopulate 
damaged tissue as well as integrate with the host to promote full recovery.  Traditionally, 
stem cell fate is guided by the addition of soluble factors to the medium.  For 
cardiomyocyte differentiation, this has involved the supplementation of BMP4 to mouse 
ESCs, and a combination of BMP4, Activin, bFGF, and Wnt to human ESCs.  While this 
differentiation strategy is quite effective for monolayer culture, the percentage of ESC-
derived cardiomyocytes (ESC-CM) derived from EBs is lower: 90-95% yields in 
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monolayer culture (Lian et al., 2013) versus approximately 30% in EBs (Laflamme et al., 
2007; Lee et al., 2011; Willems et al., 2011). 
 Electron microscopy of the EB over the course of culture has revealed that part of 
the difficulty with homogeneous ESC differentiation is overcoming diffusional 
limitations.  Approximately three days after EB formation, a collagen-rich endodermal 
cell wall forms around the EB exterior (Bratt-Leal et al., 2009; Sachlos & Auguste, 
2008).  This suggests that the most exposure cells in the EB interior have to exogenous 
factors is through the first three days, after which proteins can no longer diffuse through 
the outermost cells (Sachlos & Auguste, 2008).    
 In an attempt to overcome these limitations, the possibility of delivering soluble 
factors to the interior of EBs has been explored.  Microparticles composed of gelatin, 
Poly(lactic-co-glycolic acid) (PLGA) and agarose have been successfully incorporated 
into EBs, and have been shown to efficiently release soluble factors such as Retinoic 
Acid, ultimately promoting differentiation without impacting viability or gross 
morphology (Bratt-Leal, Carpenedo, Ungrin, Zandstra, & Mcdevitt, 2011; Bratt-Leal, 
Nguyen, Hammersmith, Singh, & Mcdevitt, 2013; Carpenedo et al., 2009).  In addition, 
the presence of these particles alone have been observed to increase the expression of 
mesodermal markers (Carpenedo et al., 2009).  Despite the potential of protein-loaded 
microspheres, this technique has only been demonstrated effective for small, hydrophobic 
molecules and not necessarily for larger proteins. 
 In addition to protein delivery strategies, alternative growth factors that enhance 
cardiomyogenesis are also being pursued.  The hedgehog signaling pathway is also 
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activated in response to myocardial infarction (Thomas, Koudijs, van Eeden, Joyner, & 
Yelon, 2008), and Sonic Hedgehog (Shh) gene therapy has been shown to enhance 
healing post-MI in rodents (Ahmed, Haider, Shujia, Afzal, & Ashraf, 2010; Kusano et al., 
2005).  SHH signaling is essential for the regulation of patterning and growth of multiple 
embryonic organs (Ingham & McMahon, 2001; Thomas et al., 2008).  In vivo, Hh 
signaling from the endoderm influences the fate of the embryonic mesoderm, guiding 
differentiation into vascular phenotypes, including cardiomyocytes (Bijlsma & Spek, 
2010; Clement et al., 2009; Gianakopoulos & Skerjanc, 2005; Kusano et al., 2005).  SHH 
induces its transcriptional response by binding to the receptor Patched (PTCH).  In the 
absence of SHH, PTCH inhibits another receptor, Smoothened (SMO).  SMO inhibition 
prevents GLI, a downstream transcription factor, from translocating into the nucleus and 
becoming activated.  When SHH binds to PTCH, the signaling cascade is activated and 
SMO inhibition is relieved, leading to GLI activation and transcription of cardiovascular 
genes.  In turn, bmp4 transcripts are upregulated by SHH signaling (Gianakopoulos & 
Skerjanc, 2009).  
 Since microparticles have been observed to influence fate determination in EBs, 
we hypothesized that the incorporation of magnetic microbeads into the EB interior may 
guide differentiation into cardiomyocytes through biological or physical interactions.   
Similarly, these magnetic beads may also be used to deliver immobilized proteins, 
specifically those that promote cardiomyogenesis, to derive a larger population of 
mesodermal progenitors.  In this chapter, we incorporated paramagnetic beads into EBs 
during aggregation and examined the effects on cardiomyocyte differentiation.  The 
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efficiency of bead incorporation was confirmed by histology, and the nature of bead 
interactions with the cells was analyzed using a focal adhesion microarray.   To assess the 
possibility of delivering immobilized proteins into EBs, 6xHis-tagged SHH and Maltose 
Binding Protein (MBP)-BMP4 were bound to anti-His or MBP magnetic beads and 
binding efficiency was confirmed by either ELISA or western blot.  The effect of protein-
immobilized beads on cardiomyocyte differentiation was analyzed by the percentage of 
EBs with spontaneous contracting foci.   We observed that the magnetic beads do appear 
to increase cardiomyocyte differentiation, likely through integrin-mediated interactions; 
however, immobilized proteins have decreased potency, and consequently do not have a 
significant effect. 
3.2. MATERIALS AND METHODS 
3.2.1.  Embryonic stem cell culture 
R1 mouse ESCs (A. Nagy, Toronto, Canada) were expanded feeder-free on 0.1% 
gelatin-coated cell culture flasks (Stem Cell Technologies, Vancouver, Canada) in 
Growth Medium containing Knockout Dulbecco’s Modified Eagle’s Medium 
(Invitrogen, Grand Island, NY) supplemented with 15% ES-Cult Fetal Bovine Serum 
(Stem Cell Technologies), 1% Glutamax (Invitrogen), 1% Non-Essential Amino Acids 
(Invitrogen), 1% Nucleosides (Millipore, Billerica, MA), 1% Penicillin/Streptomycin 
(Invitrogen), 0.1mM β-Mercaptoethanol (Invitrogen) and 103 U/ml Leukemia Inhibitory 
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Factor (LIF; Millipore).  Medium was changed in full each day, and cells were passaged 
every 2 days before reaching approximately 70% confluence. 
3.2.2.  Embryoid Body formation and Bead incorporation 
The ESCs were enzymatically released from the gelatin-coated plates with 
trypsin/EDTA (ATCC, Manassas, VA) and resuspended in differentiation medium 
(growth medium without LIF supplementation).   Aggrewell 400™ plates (Stem Cell 
Technologies) were used to facilitate ESC aggregation as directed by the manufacturer.  
To form the EBs, 1.2 x 106 cells were added to each well of the Aggrewell plate, shaken 
briefly on an orbital shaker, and centrifuged for 3 min at 100 x g, resulting in a final EB 
size of 1000 cells/EB.  The Aggrewell plates were incubated at 37°C/5% CO2 for 30 
minutes to allow the cells to settle into the wells.  Paramagnetic beads, either without 
protein or immobilized with SHH or BMP4, were resuspended in differentiation medium 
and pipetted directly into the Aggrewell plate.  The groups and concentrations of reagents 
used for the SHH and the BMP4 experiments are listed in Table 3.1.  After 72 hours, the 
EBs were removed from the wells with wide bore tips and transferred to ultra-low 
attachment plates (Corning, Lowell, MA).  The EBs were maintained in differentiation 
medium in suspension culture for 7 days.  Viability was assessed by Trypan Blue 
exclusion. 
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3.2.3. Protein immobilization to Paramagnetic Beads 
Recombinant mouse SHH with a 6x His tag (R&D Systems, Minneapolis, MN) 
was immobilized to anti-His tag magnetic Dynabeads (DBs) according to the 
manufacturer’s protocol with modifications.  A 1x Binding Buffer was diluted in PBS 
(Mediatech, Manassas, VA) from a 2x Binding Buffer containing 100 mM sodium 
phosphate pH 8.0, 600 mM sodium chloride and 0.02% tween-20 (Sigma-Aldrich, St. 
Louis, MO) and sterile filtered prior to use.  To immobilize the SHH to the DBs, 1 μg of 
SHH was combined with 40 μg of DBs in 300 μl of sterile 1x Binding Buffer.  The SHH-
Dynabead solution (Shh-DB) was incubated on an end-to-end shaker for 3 hours at 4°C.  
The SHH-DBs were pulled out of solution using a Dynal magnet (Invitrogen, Carlsbad, 
CA).    
For BMP4 studies, recombinant human BMP4 with a MBP tag (rhBMP4-MBP, 
Abcam, Cambridge, MA) was combined with Anti-MBP paramagnetic beads (New 
England Biolabs, Ipswitch, MA) at a final concentration of 10 μg protein/ mg beads.  The 
beads were first rinsed in Rinse Buffer (0.1M sodium phosphate, pH 8) prior to 
resuspension in PBS containing 2.5 μg rhBMP4-MBP on an end-to-end shaker for 1 hour 
at 4oC.  The protein-bound beads (hereafter referred to as BMP4-beads) were rinsed again 
three times in Rinse Buffer.  The beads were resuspended in medium (200 μl per 
Aggrewell) prior to transfer to the Aggrewell plate. 
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3.2.4.  Prussian Blue staining 
To assess bead loading efficiency into EBs, beads at concentrations ranging from 
10 μg to 400 μg were added to each well of an Aggewell plate.  The EBs were removed 
on Day 3 and transferred to ultra low attachment dishes for an additional 4 days.  On day 
7, the EBs were fixed with 4% buffered formalin, rinsed in PBS, and resuspended in OCT 
solution (Thermo Scientific) for cryosectioning.  Frozen sections (10 μm) were 
rehydrated for 10 minutes in PBS.  Prussian Blue staining was performed to locate the 
beads within the EBs.  The sections were incubated in a 1:1 solution of 20% aqueous 
hydrochloric acid: 10% aqueous potassium ferrocyanide for 20 minutes at room 
temperature.  Following three rinses in distilled water, the slides were counterstained in 
Nuclear Fast Red (Sigma-Aldrich) for 5 minutes at room temperature.  The slides were 
rinsed twice in distilled water, cleared and mounted with Cytoseal (Thermo Scientific).   
EBs were imaged using a Leica DMI2000B microscope with a Leica DFC290 camera. 
3.2.5.  Enzyme Linked Immunosorbent Assay 
The concentration of SHH bound to beads was assessed at Day 0, 1, 3, 5 and 7 
(n=3 per time point) using a SHH Enzyme Linked Immunosorbent Assay (ELISA; R&D 
systems, Minneapolis, MN).  SHH was immobilized to beads as described above.  
Immediately following the 3-hour incubation, SHH-beads were collected with a Dynal 
magnet and the Binding Solution was removed.  The SHH-beads were incubated in 
300mM Imidazole, 50mM sodium phosphate pH 8.0, 300mM sodium chloride and 0.01% 
Tween-20 (His-elution Buffer) overnight at 4°C on an end-to-end shaker to isolate the 
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bound Shh.  Day 1-7 samples were incubated in PBS at 37°C for the duration of the 
study, and Shh was eluted at each time point using the same procedure.  The SHH ELISA 
(R&D systems) was carried out as directed by the manufacturer. 
3.2.6.  Western Blot 
A BMP4 western blot was used to confirm rhBMP4-MBP binding efficiency to 
anti-MBP beads.  After binding the BMP4 to beads as described in Section 3.2.1, the 
BMP4-beads were incubated in PBS at 37oC/5%CO2 over 7 days.  On Days 1, 3, 5 and 7, 
the BMP4-beads were rinsed in PBS and incubated in 1x Laemmli Buffer containing β-
Mercaptoethanol (Bio-Rad) for 5 minutes at 70oC.  The BMP4-Laemmli solution was 
separated from the beads using a Dynal magnet.  The protein fraction was run on a 10% 
tris-HCl Page gel (Bio-Rad) for 1 hour at 100V.  The Page gel was transferred onto a 
PVDF membrane (Bio-Rad) at 100V for 1 hour.  After blocking for 1 hour in 5% Milk in 
TBST (Tris Buffered Saline with 0.05% Tween-20), the blots were incubated in rabbit 
anti-mouse BMP4 primary antibody (Abcam, 1:500 in 5% Milk/TBST) overnight at 4oC.  
The blot was incubated in goat anti-rabbit IgG HRP (Abcam, 1:2000 in 5% Milk/TBST) 
for 1 hour at room temperature.  After three rinses in TBST, the blots were developed 
with SuperSignal West Pico Substrate (Thermo Scientific) as directed by the 
manufacturer, and images were obtained with a FluorChem HD2 digital imager (Protein 
Simple, Santa Clara, CA).   Band intensity was calculated and analyzed using AlphaView 
software (Protein Simple).  Soluble BMP4 at the same concentration in PBS was included 
as a control. 
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3.2.7.  Focal Adhesion Protein PCR Array 
To determine potential binding interactions with beads and the ESCs, we 
performed a Focal Adhesions PCR Array (SA Biosciences, Valencia, CA).  EBs were 
formed using Aggrewell plates as described in Section 3.2.2.  Day 1 EBs containing 20 
μg beads were compared to controls without beads.  RNA was isolated using an RNeasy 
mini kit (Qiagen).  Following RNA isolation, 500 ng RNA was reverse transcribed using 
the RT2 First Strand Reverse Transcription kit (SA Biosciences) and a Veriti Thermal 
Cycler (Invitrogen) at the following conditions: 15 minutes at 42oC, and 5 minutes at 
95oC.  Following dilution in RNase free water, the cDNA was mixed with one volume of 
2x RT2 SYBR Green Master Mix (SA Biosciences) and added to each well of the 
Microarray.  The PCR products were amplified with a ViiA 7TM Real Time Polymerase 
Chain Reaction (PCR; Life Technologies) system under the following conditions: 95oC 
for 10 minutes for one cycle, 15 seconds at 95oC followed by 1 minute at 60oC for 40 
cycles.  The results were analyzed using the RT2 ProfilerTM PCR array data analysis 
program (SA Biosciences).  
3.2.8.  Gli1-response assay 
For RNA extraction, EBs were rinsed in PBS and disrupted using a QIAshredder 
kit as recommended by the manufacturer (Qiagen).  RNA was further extracted using an 
RNeasy Mini kit (Qiagen).  Total RNA was calculated using a BioTek plate reader 
(BioTek, Winooski, VT).  A 100ng sample of RNA was reverse transcribed to cDNA 
using a High-Capacity Reverse Transcription kit (Life Technologies) and Veriti Thermal 
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Cycler (Invitrogen) as recommended by the manufacturer.  To assess the activity of His-
tagged SHH, we compared Gli1 transcriptional activation to the Shh agonist 
StemoleculeTM Purmorphamine (Stemgent, Cambridge, MA) as described previously with 
some modifications (Frank-Kamenetsky et al., 2002).  ESCs were cultured on gelatin-
coated tissue culture plastic in growth medium containing LIF.  After 24 hours, the cells 
were changed to 0.5% serum growth medium containing 1-100nM purmorphamine or 
His-tagged Shh.  After 24 hours of exposure, the RNA was collected and isolated as 
described in Section 3.2.7.  RT-PCR was performed using the inventoried Gli1 TaqMan 
assay Mm00494654_m1 (Life Technologies). 
3.2.9.  Contractile activity 
The spontaneous development of contracting foci within EBs was analyzed as 
described previously with a few modifications (Sargent, Berguig, & Mcdevitt, 2009).   
On Day 7, single EBs were transferred from the ultra-low attachment plates to individual 
wells of 0.1% gelatin-coated 48-well plates.  At least 10-15 EBs were transferred for each 
group with an n=3.  On Days 8, 10, 12, and 14, the number of EBs with spontaneously 
contracting areas was recorded.   
3.2.10.  Statistics 
Statistical analysis was performed using StatPlus LE (AnalystSoft).  All groups 
analyzed represent three independent experiments.  Data from each of the groups was 
compared using one-way ANOVA coupled with Tukey’s HSD test for differences 
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between means.  Values are reported as mean ± standard deviation unless indicated 
otherwise.  p-values less than 0.05 were considered statistically significant. 
3.3.  RESULTS 
3.3.1.  Bead incorporation into EBs  
Since our objective was to expose cells within the EB to as many beads as 
possible, we delivered a range of bead concentrations to EBs in the Aggrewell plates and 
stained them with Prussian Blue (Figure 3.1) to examine distribution.  Very few beads 
were detectable in EBs loaded with 10-50 μg beads per well (Figure 3.1D,E).  Slight 
increases in staining were observed in EBs containing 100 to 500 μg beads (Figure 3.1A-
C). 
3.3.2.  Effect of beads on focal adhesion protein expression 
Previous reports have suggested that the presence of microparticles alone increase 
mesodermal commitment in EBs (Carpenedo et al., 2009).  To better understand the 
interactions between magnetic beads and the cells, we performed a Focal Adhesion 
Protein (FAP) microarray to investigate which extracellular proteins are being activated 
and upregulated in response to bead exposure.  After incubating the EBs with Anti-His 
beads for 24 hours, we compared transcript expression of FAPs to control EBs.  The 
presence of the beads increased Integrin α1 (Itga1) expression 3.2-fold compared to EBs 
without beads (Figure 3.2A,B).  Expression of Integrin β1 (Itgb1), the subunit that 
comprises the α1β1 heterodimer, decreased 1.28-fold compared to controls.  Slight 
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increases were also observed in Protein Kinase b (Prkcb, 1.55-fold), ras-related C3 
botulinum toxin substrate 2 (Rac2, 1.46-fold) and Son of Sevenless 2 (Sos2, 1.38-fold).   
3.3.3.  Effect of Shh-beads on EB viability 
After confirming that beads could be incorporated into the EBs, we next assessed 
the effect of protein-immobilized beads on cardiomyogenesis.  SHH has been observed to 
guide differentiation of cells into cardiovascular phenotypes via activation of the 
transcription factor GLI1 (Figure 3.3).  We first assessed the efficiency and stability of 
SHH binding to anti-His tagged beads.  To ensure maximum SHH loading to the beads, 
155 ng of SHH was combined with 20 μg of Dynabeads for 3 hours as suggested by the 
manufacturer.  We calculated that the final concentration of bound SHH was 
approximately 9.3x105 molecules of SHH/μg beads (or 15.5±3.3 pmol SHH/μg beads; 
Figure 3.4A).  To determine the stability of bound SHH, we measured the amount of 
SHH bound to the beads over the course of 7 days in culture at 37oC/5%CO2 by ELISA.  
Following elution of the protein from the beads, we found that traces of SHH remained 
on the beads through Day 7 (Figure 3.4B).   
After establishing the binding efficiency of SHH to beads, we incorporated the 
SHH-beads into the EBs using Aggrewell plates (Figure 3.4C).  After 24 hours, we 
measured the percentage of living and dead cells by Trypan blue dye exclusion.  
Regardless of the presence of beads, no significant differences in viability were observed 
(Figure 3.4D). 
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3.3.4.  Effect of Shh-beads on contractile activity 
 To investigate the effect of SHH-beads on cardiomyogenesis, the EBs were plated 
on Day 7 and the percentage of EBs with contracting areas was recorded (Figure 3.5).  
Contractile activity in all groups was observed 3 days after plating (Day 7+3).  After 12 
days (Day 7+5), there was approximately a 2-fold increase in contractile activity in all 
treatment groups compared to controls.  Contractile activity returned to levels comparable 
to the control without SHH or beads by Day 14 (Day 7+7). 
3.3.5.  Preparation of BMP4-beads and loading optimization 
In addition to His-tagged SHH, we also examined the effect of bead immobilized 
BMP4 on cardiomyogenesis in EBs, since BMP4 is the most common protein used to 
direct mesodermal commitment in ESCs.  RhBMP4 with MBP tags were combined with 
Anti-MBP paramagnetic beads (Figure 3.6A) and the binding stability was assessed by 
western blot (Figure 3.6B).  Over the course of seven days in vitro, the amount of BMP4 
eluted from the beads was relatively unchanged: approximately 80% of the initial BMP4 
concentration was detected throughout the incubation period (Figure 3.6C).  In 
comparison, the concentration of soluble, tagged BMP4 decreased more quickly, such 
that only 30% of the initial BMP4 concentration was detectable by Day 7. 
3.3.6.  Effect of BMP4-Beads on contractile activity 
 To examine the differentiated cardiomyocyte phenotype, we plated the EBs 
containing BMP-beads on Day 7 (Figure 3.7).  By Day 14, increases in contractile 
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activity were observed in EBs exposed to low concentrations of both soluble BMP4 
(6%±6% versus 2%±4% in high concentration groups) and immobilized BMP4 
(13%±6% versus 4%±4% in high concentration groups).  The only group that displayed 
significant increases in contractile activity by Day 14 were the EBs containing 400 μg 
unbound beads (19%±10%).  No significant differences were observed between EBs with 
low concentrations of unbound beads compared to controls. 
3.3.7.  Comparison of SHH-bead and purmorphamine potency  
 Due to the inconsistent effects on contractile activity, we assessed the 
effectiveness of His-tagged SHH to increase transcript levels of the transcription factor 
Gli1.  The ESCs were exposed to 1 – 100 nM of His-tagged SHH or purmorphamine in 
serum-free medium for 24 hours prior to RNA isolation.  We observed that 
purmorphamine was significantly more potent, increasing Gli1 gene expression almost 8-
fold at 100 nM (Figure 3.8) compared to controls.  Only a 2-fold change in Gli1 
expression was observed in the presence of 50 nM His-tagged SHH.  As a comparison, 
approximately 52 nM His-tagged SHH is delivered to EBs via beads on Day 0. 
3.4. DISCUSSION 
Successful development of an MI patch requires (1) a stable, biocompatible 
material to retain cells at the infarct site and (2) a population of cardiomyocytes or 
cardiomyocyte progenitors that can replace the necrotic tissue.  While differentiation of 
ESCs in monolayer culture yields approximately 95% cardiomyocytes, optimizing EB 
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culture methods could potentially further increase this percentage.  The low 
cardiomyocyte yields from EBs have been partially attributed to the development of a 
thick visceral endoderm layer composed primarily of collagen starting around day 3 after 
ESC aggregation.  Diffusional assays using Methylene Blue, a dye with a molecular 
weight of 320 Da, was shown to readily diffuse through EBs on day 3; however, 
diffusion decreased 80% by day 7 (Sachlos & Auguste, 2008).  To address this issue, the 
idea of entrapping or attaching proteins to microparticles has been explored (Bratt-Leal et 
al., 2011; Carpenedo et al., 2009). 
Previous reports have demonstrated that the presence of microparticles alone 
within an EB can direct lineage commitment; however, the nature of the interaction 
between particles and the cells is unclear (Carpenedo et al., 2009).  We also observed that 
the presence of paramagnetic beads inside the EBs was sufficient to increase the 
contractile phenotype.  Regardless of whether SHH (Figure 3.5) or BMP4 (Figure 3.7) 
were immobilized to beads, cardiomyogenesis was most influenced by the presence of 
un-immobilized beads.   The microarray results clarify this, since after 24 hours the gene 
most predominantly upregulated compared to control EBs without beads was Itga1 
(integrin α1) (Figure 3.2).  Integrin heterodimer α1β1 is the major receptor for collagen 
in vivo (Louis et al., 2007).  The α subunit of the heterodimer plays an important role in 
protein-ligand binding coordination with the β subunit (Srichai & Zent, 2009).  
Activation of the α and β subunits leads to both clustering of the actin cytoskeleton, and 
activation of integrin-mediated signaling pathways (“outside-in signaling”).  Similarly, 
the collagen-β1 integrin binding interaction is necessary for both proper EB formation 
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and subsequently ESC differentiation into cardiomyocytes (Zeng et al., 2013).  The 
increase in Itga1 gene expression suggests that the beads are interacting directly with the 
cells via integrin α1.  While Itgb1 expression was not significantly changed by the 
presence of the beads, it is possible that gene expression could increase at a later time 
point.  Since integrin heterodimers mediate outside-in signaling in response to 
mechanical signals (Aikawa et al., 2002), this may explain why unbound beads alone can 
have an effect on cardiomyogenesis; however, integrin α1 and β1 blocking experiments 
would be necessary to confirm this possibility. 
While SHH has been observed to promote angiogenesis and also improve 
recovery following myocardial infarction (Gianakopoulos & Skerjanc, 2005; Kusano et 
al., 2005; Renault et al., 2010; Vokes et al., 2004), its effect on directing differentiation in 
EBs has not yet been assessed.  For this reason, we examined the effect of immobilized 
SHH on (1) overcoming EB diffusional limitations and (2) influencing differentiation 
into cardiomyocytes.  Our preliminary data demonstrated that His-tagged SHH could be 
stably bound to beads and remained bound for up to 7 days in vitro (Figure 3.4); 
however, there was no effect on contractile activity (Figure 3.5).  The Gli1 transcript 
expression data clarified the possible reason for this: since Gli1 expression is 
significantly higher following exposure to the SHH agonist purmorphamine as compared 
to His-SHH (Figure 3.8), this suggests that the potency of tagged SHH is insufficient to 
induce a biological response in ESCs.  Since contractile activity was similarly unaffected 
in our BMP4 group, we could conclude that tagged-BMP4 is insufficient for the same 
reason.  This was confirmed by western blot results, in which tagged BMP4 did not 
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increase SMAD1/5/8 expression, a downstream target of BMP4 (Figure 3.3), at any of 
the concentrations tested (data not shown).  Therefore, while we cannot conclude that 
controlled delivery of proteins such as SHH or BMP4 into the EB interior have no effect 
on cardiomyogenesis, delivery of tagged proteins appear not to be effective.  
3.5.  CONCLUSIONS 
 In this chapter, we confirmed previous findings that microparticles, such as 
paramagnetic beads, can influence differentiation into cardiomyocyte phenotypes, and 
this is most likely the result of α1β1 integrin binding interactions.  Due to the decreased 
potency of tagged SHH and BMP4, we were unable to confirm the potential of localized 
delivery of these proteins on fate determination.  In regards to SHH, another option to 
investigate the potential of SHH on mesodermal commitment is the soluble delivery of 
agonists such as purmorphamine.  Purmorphamine (520 Da) is a smaller protein 
compared to Shh (49,607 Da) and may better penetrate the thick, collagen layer 
comprising the EB endoderm.   In the future, we may further increase cardiomyogenesis 
by combining the mechanical interactions between cells and beads with biological cues, 
either delivered in microparticles or in soluble form. 
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Table 3.1.  Concentrations of Shh and BMP4 used in protein-immobilized bead 
experiments. 
Protein Group Abbreviation 
Protein 
concentration/well 
Bead 
concentration/well 
Shh 
Control C -- -- 
DB B -- 20 μg 
Shh S 155 ng -- 
Shh-DB SD 155 ng 20 μg 
BMP4 
Control C -- -- 
Low [Beads] LD -- 10 μg 
High [Beads] HD -- 400 μg 
Low [BMP] LB 62.5 ng -- 
High [BMP4] HB 2.5 μg -- 
Low [BMP4-
Beads] 
LBD 
62.5 ng 10 μg 
High [BMP4-
Beads] 
HBD 
2.5 μg 400 μg 
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Figure 3.1:  Prussian Blue staining of Day 7 EBs containing serial dilutions of 
paramagnetic beads.  A range of bead concentrations was added to the 
Aggrewells, from 400μg/well to 10μg/well.  Blue: beads, red: Nuclear Fast 
Red.  Scale = 100 μm. 
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Figure 3.2: Focal Adhesion Protein expression of EBs containing unbound beads.  The 
expression of focal adhesion proteins were compared between unloaded 
controls and bead-containing EBs 24 hours after EB formation.  (A) Heat 
map of focal adhesion proteins. Highlighted boxes depict increased 
expression of proteins in bead-containing EBs. (B) Changes in transcript 
levels between bead-containing EBs and controls.   
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Figure 3.3.  SHH and BMP signaling pathway overview.  Shh binding to PTCH relieves 
Ptc inhibition of the receptor SMO.  Activation of SMO results in the 
translocation of transcription factor GLI1 into the nucleus.  BMP4 binds to 
serine-threonine kinase receptors, which results in signal transduction via 
the SMAD and MAP kinase pathways.  Adapted from Anderson and 
Darshan, 2008 (Anderson & Darshan, 2008). 
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Figure 3.4: Efficiency of SHH-immobilization to beads and effect on cell viability.  (A) 
His-tagged recombinant mouse SHH and Anti-His tag beads were co-
incubated as recommended by the manufacturer to yield 9.3x105 molecules 
of SHH/μg bead.  (B) Viability of EBs with immobilized beads was 
unaffected compared to controls.  Scale bars: standard deviation. 
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Figure 3.5: Minimal changes in contractile activity were observed in Bead- and SHH-
treated groups.  Only Day 12-EBs (5 days after plating Day 7-EBs on 
gelatin-coated plastic) showed significantly increased numbers of contractile 
cells compared to unloaded controls.  Bars: standard error of the mean.  
*p<0.05. 
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Figure 3.6: Efficiency of immobilizing BMP4-MBP to Anti-MBP paramagnetic beads.  
(A) 2.5 μg of BMP4 with a MBP tag was immobilized to 400 μg anti-MBP 
paramagnetic beads as directed by the manufacturer.  (B) Concentration of 
eluted or soluble BMP4 detected on beads.  (C) Relative pixel intensity of 
Western Blot bands in (B).  Band intensity was normalized to Day 0 protein 
levels. 
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Figure 3.7:  Contractile activity in EBs loaded with BMP4-beads.  Contractile activity in 
EBs was monitored from Days 8 through 14. *p<0.05. Bars: standard error 
of the mean.   
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Figure 3.8: His-tagged SHH is less potent than the SHH agonist Purmorphamine.  ESCs 
were incubated in low serum for 24 hours and supplemented with varying 
concentrations of His-tagged SHH or Purmorphamine.  Gli1 transcript 
expression was significantly higher in Purmorphamine-treated samples than 
His-tagged SHH-treated samples.  Bars: standard deviation. *p<0.05. 
  
 70 
3.6.  REFERENCES 
Ahmed, R. P. H., Haider, K. H., Shujia, J., Afzal, M. R., & Ashraf, M. (2010). Sonic 
Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-
1/PKC pathway. Plos One, 5(1), e8576. doi:10.1371/journal.pone.0008576 
 
Aikawa, R., Nagai, T., Kudoh, S., Zou, Y., Tanaka, M., Tamura, M., et al. (2002). 
Integrins play a critical role in mechanical stress-induced p38 MAPK activation. 
Hypertension, 39(2), 233–238. 
 
Anderson, G. J., & Darshan, D. (2008). Small-molecule dissection of BMP signaling. 
Nature Chemical Biology, 4(1), 15–16. doi:10.1038/nchembio0108-15 
 
Bijlsma, M. F., & Spek, C. A. (2010). The Hedgehog morphogen in myocardial 
ischemia-reperfusion injury. Experimental Biology and Medicine (Maywood, N.J.), 
235(4), 447–454. doi:10.1258/ebm.2009.009303 
 
Bratt-Leal, A. M., Carpenedo, R. L., & Mcdevitt, T. C. (2009). Engineering the embryoid 
body microenvironment to direct embryonic stem cell differentiation. Biotechnology 
Progress, 25(1), 43–51. doi:10.1002/btpr.139 
 
Bratt-Leal, A. M., Carpenedo, R. L., Ungrin, M. D., Zandstra, P. W., & Mcdevitt, T. C. 
(2011). Incorporation of biomaterials in multicellular aggregates modulates 
pluripotent stem cell differentiation. Biomaterials, 32(1), 48–56. 
doi:10.1016/j.biomaterials.2010.08.113 
 
Bratt-Leal, A. M., Nguyen, A. H., Hammersmith, K. A., Singh, A., & Mcdevitt, T. C. 
(2013). A microparticle approach to morphogen delivery within pluripotent stem cell 
aggregates. Biomaterials, 34(30), 7227–7235. 
doi:10.1016/j.biomaterials.2013.05.079 
 
Carpenedo, R. L., Bratt-Leal, A. M., Marklein, R. A., Seaman, S. A., Bowen, N. J., 
Mcdonald, J. F., & Mcdevitt, T. C. (2009). Homogeneous and organized 
differentiation within embryoid bodies induced by microsphere-mediated delivery of 
small molecules. Biomaterials, 30(13), 2507–2515. 
doi:10.1016/j.biomaterials.2009.01.007 
 
Clement, C. A., Kristensen, S. G., Møllgård, K., Pazour, G. J., Yoder, B. K., Larsen, L. 
A., & Christensen, S. T. (2009). The primary cilium coordinates early cardiogenesis 
and hedgehog signaling in cardiomyocyte differentiation. Journal of Cell Science, 
122(17), 3070–3082. doi:10.1242/jcs.049676 
 
Frank-Kamenetsky, M., Zhang, X. M., Bottega, S., Guicherit, O., Wichterle, H., Dudek, 
 71 
H., et al. (2002). Small-molecule modulators of Hedgehog signaling: identification 
and characterization of Smoothened agonists and antagonists. Journal of Biology, 
1(2), 10. 
 
Gianakopoulos, P. J., & Skerjanc, I. S. (2005). Hedgehog signaling induces 
cardiomyogenesis in P19 cells. The Journal of Biological Chemistry, 280(22), 
21022–21028. doi:10.1074/jbc.M502977200 
 
Gianakopoulos, P. J., & Skerjanc, I. S. (2009). Cross talk between hedgehog and bone 
morphogenetic proteins occurs during cardiomyogenesis in P19 cells. In Vitro 
Cellular & Developmental Biology. Animal, 45(9), 566–572. doi:10.1007/s11626-
009-9228-z 
 
Ingham, P. W., & McMahon, A. P. (2001). Hedgehog signaling in animal development: 
paradigms and principles. Genes & Development, 15(23), 3059–3087. 
doi:10.1101/gad.938601 
 
Kusano, K. F., Pola, R., Murayama, T., Curry, C., Kawamoto, A., Iwakura, A., et al. 
(2005). Sonic hedgehog myocardial gene therapy: tissue repair through transient 
reconstitution of embryonic signaling. Nature Medicine, 11(11), 1197–1204. 
doi:10.1038/nm1313 
 
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. 
K., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-
survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 
25(9), 1015–1024. doi:10.1038/nbt1327 
 
Lee, M. Y., Bozkulak, E. C., Schliffke, S., Amos, P. J., Ren, Y., Ge, X., et al. (2011). 
High density cultures of embryoid bodies enhanced cardiac differentiation of murine 
embryonic stem cells. Biochemical and Biophysical Research Communications, 
416(1-2), 51–57. doi:10.1016/j.bbrc.2011.10.140 
 
Lian, X., Zhang, J., Azarin, S. M., Zhu, K., Hazeltine, L. B., Bao, X., et al. (2013). 
Directed cardiomyocyte differentiation from human pluripotent stem cells by 
modulating Wnt/β-catenin signaling under fully defined conditions. Nature 
Protocols, 8(1), 162–175. doi:10.1038/nprot.2012.150 
 
Louis, H., Kakou, A., Regnault, V., Labat, C., Bressenot, A., Gao-Li, J., et al. (2007). 
Role of alpha(1)beta(1)-integrin in arterial stiffness and angiotensin-induced arterial 
wall hypertrophy in mice. American Journal of Physiology Heart and Circulatory 
Physiology, 293(4), H2597–H2604. doi:10.1152/ajpheart.00299.2007 
 
Renault, M.-A., Roncalli, J., Tongers, J., Thorne, T., Klyachko, E., Misener, S., et al. 
 72 
(2010). Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in 
endothelial cells. Journal of Molecular and Cellular Cardiology, 49(3), 490–498. 
doi:10.1016/j.yjmcc.2010.05.003 
 
Sachlos, E., & Auguste, D. T. (2008). Embryoid body morphology influences diffusive 
transport of inductive biochemicals: A strategy for stem cell differentiation. 
Biomaterials, 29(34), 4471–4480. doi:10.1016/j.biomaterials.2008.08.012 
 
Sargent, C. Y., Berguig, G. Y., & Mcdevitt, T. C. (2009). Cardiomyogenic differentiation 
of embryoid bodies is promoted by rotary orbital suspension culture. Tissue 
Engineering Part A, 15(2), 331–342. doi:10.1089/ten.tea.2008.0145 
 
Srichai, M. B., & Zent, R. (2009). Integrin Structure and Function. In R. Zent & A. Pozzi, 
(pp. 19–41). New York, NY: Springer New York. doi:10.1007/978-1-4419-0814-8_2 
 
Thomas, N. A., Koudijs, M., van Eeden, F. J. M., Joyner, A. L., & Yelon, D. (2008). 
Hedgehog signaling plays a cell-autonomous role in maximizing cardiac 
developmental potential. Development, 135(22), 3789–3799. 
doi:10.1242/dev.024083 
 
Vokes, S. A., Yatskievych, T. A., Heimark, R. L., McMahon, J., McMahon, A. P., Antin, 
P. B., & Krieg, P. A. (2004). Hedgehog signaling is essential for endothelial tube 
formation during vasculogenesis. Development, 131(17), 4371–4380. 
doi:10.1242/dev.01304 
 
Willems, E., Spiering, S., Davidovics, H., Lanier, M., Xia, Z., Dawson, M., et al. (2011). 
Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes 
from human embryonic stem cell-derived mesoderm. Circulation Research, 109(4), 
360–364. doi:10.1161/CIRCRESAHA.111.249540 
 
Zeng, D., Ou, D.-B., Wei, T., Ding, L., Liu, X.-T., Hu, X.-L., et al. (2013). Collagen/β(1) 
integrin interaction is required for embryoid body formation during cardiogenesis 
from murine induced pluripotent stem cells. BMC Cell Biology, 14, 5. 
doi:10.1186/1471-2121-14-5 
 
  
 73 
CHAPTER FOUR 
Magnetically mediated strain guides mouse embryonic stem cell 
differentiation into cardiomyocytes 
Mechanical forces play an important role in proper embryologic development, 
and similarly such forces can directly impact pluripotency and differentiation of mouse 
embryonic stem cells (mESC) in vitro.  In this study, we developed a mechanical 
stimulation regimen using permanent neodymium magnets to magnetically attract cells 
within an embryoid body (EB).  Arginine-Glycine-Aspartic Acid (RGD)-conjugated 
paramagnetic beads were incorporated into the interior of the EBs during aggregation, 
allowing us to exert force on individual cells using short-term magnetization.  EBs were 
stimulated for one hour at different magnetic field strengths, subsequently exerting a 
range of force intensity on the cells at different stages of early EB development.  Our 
results demonstrated that following exposure to a 0.2 Tesla magnetic field, ESCs respond 
to magnetically mediated strain by activating Protein Kinase A (PKA) and increasing 
phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2) expression.  The 
timing of stimulation can also be tailored to guide ESC differentiation: the combination 
of bone morphogenetic protein 4 (BMP4) supplementation with one hour of magnetic 
attraction on Day 3 enhances cardiomyogenesis by increasing contractile activity and the 
percentage sarcomeric α-actin-expressing cells compared to control samples with BMP4 
alone.  Together these results suggest that magnetically mediated strain can be used to 
increase the percentage of mouse ESC-derived cardiomyocytes over current 
differentiation protocols. 
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4.1.  INTRODUCTION 
Myocardial Infarction (MI) is one of the most prevalent diseases in America, 
accounting for approximately 50% (7.6 million) of the 15.4 million Americans suffering 
from coronary heart disease (Go et al., 2013). As an alternative to invasive surgical 
treatment options, cell therapy holds promise in promoting recovery following heart 
failure.  For this strategy to be effective in a clinical setting, an adequate cardiomyocyte 
cell source must be identified.  Differentiation of cardiomyocytes from progenitor cells 
such as pluripotent stem cells (PSCs) has the most potential to derive a large enough 
population to be a clinically relevant source. The most effective differentiation regimens 
include the addition of bone morphogenetic protein 4 (BMP4) to mouse embryonic stem 
cells (mESCs), as well as the supplementation of basic Fibroblast Growth Factor (bFGF), 
Activin, and Wnt to human embryonic stem cell (hESC) cultures (Yamashita et al., 
2000). While the highest purity of the differentiated cardiomyocyte population is 
generated from ESC monolayer culture (up to 90-95% cardiomyocytes from hESCs) 
(Lian et al., 2013), establishing a protocol to efficiently differentiate ESCs within an 
embryoid body (EB) could potentially increase the final cell yield, which is a bottleneck 
for the clinical use of ESC-derived cardiomyocytes.  To date, the highest cardiomyocyte 
yield from murine EB culture is approximately 20% (M. Y. Lee et al., 2011). 
Mechanical stimulation has been well demonstrated to direct differentiation of 
many progenitor cell types, including ESCs. A variety of stimulation regimens have been 
used to differentiate PSCs into cardiomyocytes, the most common being fluid shear and 
cyclic strain (Geuss & Suggs, 2013). In general, the onset and duration of stimulation can 
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have the most profound effects on cardiomyogenesis.  Short durations of cyclic strain in 
Day 4-6 mouse EBs increase the expression of CX 43 and mesodermal marker NKX 2.5 
(Gwak et al., 2008; Heo & Lee, 2011; Schmelter, Ateghang, Helmig, Wartenberg, & 
Sauer, 2006), while exposure to strain at later time points (after Day 9) can inhibit mESC 
differentiation (Wan, Chung, & Kamm, 2011). In hESC monolayers, earlier exposure 
(Day 1 through 4) has been demonstrated to increase α-actinin expression and alignment 
(Tulloch et al., 2011). In Day 1 mouse ESC monolayers, as little as 30 minutes exposure 
to 10 dyn/cm2 shear stress increases cardiovascular marker expression compared to 
controls (Toh & Voldman, 2011). Similar magnitudes have also been effective on Day 3 
EBs attached to tissue culture plastic (Wolfe, Leleux, Nerem, & Ahsan, 2012). 
Magnetic Twisting Cytometry (MTC) is another stimulation technique that has 
been widely used to study mechanotransduction in cells (Laboureau, Dubertret, Lebreton-
De Coster, & Coulomb, 2004; Plopper & Ingber, 1993; N. Wang, Butler, & Ingber, 
1993). This technique employs Arginine-Glycine-Aspartic Acid (RGD)-coated 
paramagnetic beads, which when attached to the cell surface via integrins induce strain 
on the cell during magnetization.  MTC has recently been used to demonstrate that 
integrin-mediated forces can decrease pluripotency in mESCs (Chowdhury et al., 2009; 
Uda et al., 2011). In these experiments, single mESCs were plated and attached to RGD-
Beads.  The cells were exposed to an oscillatory stress (17.5 Pa and 0.3 Hz) for one hour, 
and changes in pluripotency marker expression were examined over time.  The authors 
discovered that only an hour of stimulation was required to significantly decrease OCT 
3/4 24 hours after exposure.  These results demonstrated that pluripotency in ESCs can be 
 76 
linked to integrin-RGD interactions and manipulation; however, the effects on terminal 
differentiation are still not well understood. 
A challenge with mechanical stimulation of EBs is obtaining homogenous 
exposure of all cells within the EB to a similar magnitude of stress.  In addition, few 
studies have compared the combinatorial effect of biochemical supplementation and 
mechanical stimulation.   In this study, we hypothesized that magnetization of RGD-
immobilized beads within an EB can activate stress-dependent signaling pathways in 
ESCs, and subsequently increase the population of cardiomyocytes.  We have adapted the 
MTC-stimulation regimen by loading mouse EBs with RGD-beads and have examined 
the effect of magnetization at the earliest stages of EB development.  Here, we report that 
magnetization directs lineage commitment in EBs, and the terminal phenotype is 
influenced by the onset of stimulation. 
4.2.  MATERIALS/METHODS 
4.2.1.  Embryonic Stem Cell Culture 
R1 mouse ESCs (A. Nagy, Toronto, Canada) were expanded feeder-free on 0.1% 
gelatin-coated cell culture flasks (Stem Cell Technologies, Vancouver, Canada) in 
Growth Medium containing Knockout Dulbecco’s Modified Eagle’s Medium 
(Invitrogen, Grand Island, NY) supplemented with 15% ES-Cult Fetal Bovine Serum 
(Stem Cell Technologies), 1% Glutamax (Invitrogen), 1% Non-Essential Amino Acids 
(Invitrogen), 1% Nucleosides (Millipore, Billerica, MA), 1% Penicillin/Streptomycin 
(Invitrogen), 0.1mM β-Mercaptoethanol (Invitrogen) and 103 U/ml Leukemia Inhibitory 
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Factor (LIF; Millipore).  Medium was changed in full each day, and cells were passaged 
every 2 days before reaching approximately 70% confluence. 
4.2.2.  Bead Preparation 
RGD-Beads were prepared as previously described, with a few modifications 
(Laboureau et al., 2004; Plopper & Ingber, 1993). Briefly, 50 μg Peptite 2000 (Advanced 
Biomatrix, San Diego, CA) was bound to 1 mg of 1 μm BcMagTM tosyl-activated 
paramagnetic beads (Bioclone, San Diego, CA) for 72 hours at 4oC in 0.1M Carbonate 
Buffer, pH 9 as suggested by the manufacturer.  Acetylated-Low Density Lipoprotein 
(AcLDL, Biomedical Technologies, Stoughton, MA), which does not bind integrins or 
support stress transfer across the cell membrane (Maniotis, Chen, & Ingber, 1997), was 
used as a negative control and immobilized to the beads at the same concentration (50 μg 
protein/mg beads).  The protein-bound beads were rinsed three times in PBS containing 
calcium and magnesium with a Dynal magnet (Invitrogen) and blocked for 1 hour in PBS 
containing 5% Bovine Serum Albumin (Sigma-Aldrich, St. Louis, MO).  Following an 
additional three rinses in PBS, the beads were resuspended in medium and added to the 
Aggrewell 400TM plates at 1 mg beads per well. 
4.2.3.  Embryoid Body Formation and Bead Incorporation 
ESCs were enzymatically released from the gelatin-coated plates with 
trypsin/EDTA (ATCC, Manassas, VA) and resuspended in Differentiation Medium 
(Growth Medium without LIF).  Approximately 1.2 million cells were added to each well 
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of a 24-well Aggrewell 400TM plate (Stem Cell Technologies) as directed by the 
manufacturer.  The final EB sizes were approximately 1,000 cells/EB.  Once the EBs 
were allowed to settle for 30 minutes at 37oC/5%CO2, the beads were distributed to the 
appropriate wells.  The EBs were kept in the Aggrewell 400TM plates for 3 days, and 
medium was partially changed daily.  Day 3 EBs were transferred to suspension culture 
in ultra-low attachment plates and medium was changed in full every 2 days.  In the 
BMP4-treated group, 10 ng/ml BMP4 was added from Days 1 through 7 as described 
previously (Taha & Valojerdi, 2008). On Day 7, the EBs were allowed to attach to 
gelatin-coated plates and maintained for up to 18 days at 37oC/5%CO2. 
4.2.4.  EB viability 
EB viability was evaluated on Day 2 and Day 7 with a live/dead viability kit (Life 
Technologies) as described previously with a few modifications (Hwang et al., 2009).  At 
each timepoint, the EBs were collected and rinsed in PBS containing calcium and 
magnesium and incubated in 2 μM calcein-AM and 4 μM ethidium homodimer diluted in 
PBS for 30 minutes at 37oC on an end-to-end shaker.  The EBs were imaged using a 
Zeiss scanning confocal microscope.  Live and dead cells were labeled with calcein-AM 
(green) and ethidium homodimer (red), respectively.  
4.2.5.  β1 integrin inhibition 
For β1 integrin blocking experiments, ESCs were trypsinized and incubated in 
500 μg/ml Gly-Arg-Gly-Asp-Ser (GRGDS; Anaspec Inc, Fremont, CA) in serum-free 
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growth medium containing 103 U/ml LIF to prevent aggregation.  The ESCs were 
incubated in ultra-low attachment plates at 37oC/5%CO2 for 4 hours with gentle shaking.  
Immediately following incubation, the ESCs were aggregated using Aggrewell 400TM 
plates as described previously. 
4.2.6.  Spontaneous contractile activity 
 The presence of contractile areas in EBs was assessed as described previously 
(Sargent, Berguig, & Mcdevitt, 2009; Taha & Valojerdi, 2008). After 7 days of 
suspension culture, EBs were transferred to a 0.1% gelatin-coated 48-well plate using a 1 
ml wide bore tip.  Approximately 1-2 EBs were added to each well for a final count of 
10-15 EBs per group.  The EBs were monitored for 10 days after plating, with 70% 
medium changes every 2 days.  At each timepoint, the percentage of EBs with contractile 
areas was calculated relative to the total number of EBs per group.    
4.2.7.  Flow Cytometry 
EBs were collected on Day 18 to measure sarcomeric α-actin as described 
previously with a few modifications (Sargent et al., 2009). Following dissociation in 
Accumax (Stem Cell Technologies), the ESCs were incubated in anti-mouse sarcomeric 
α-actin (5c5, Sigma-Aldrich; 0.2 μl/100 μl reaction) for 45 minutes at room temperature 
in the dark with rotation.  Mouse IgM isotype controls (Stem Cell Biotechnology) were 
included.  Following another three rinses, the cells were incubated with goat anti-mouse 
IgM FITC (Stem Cell Biotechnology) for 30 minutes in the dark.  The ESCs were 
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resuspended in 500 μl cold PBS at a final concentration of 1x106 cells/ml.  The number of 
sarcomeric α-actin positive cells was analyzed using an Accuri C6 Flow Cytometer (BD 
Biosciences) to capture a minimum of 10,000 events.  Positive gates were set at 1% of the 
isotype control population.  Analysis was performed using FlowJo software (Tree Star 
Inc, Ashland, OR). 
4.2.8.  SDS-Page and Western Blotting 
Immediately following magnetization, EBs were collected from Aggrewell 400TM 
plates, rinsed in PBS, and disrupted in cold RIPA buffer (Santa Cruz Biotechnology, 
Santa Cruz, CA).  The suspension was centrifuged for 10 minutes at 10,000xg at 4oC.  
The supernatant was transferred to a 10 kDa MWCO filter unit (Millipore, Billerica, MA) 
and centrifuged at 10,000xg for 4 minutes at room temperature to concentrate the protein 
fraction.  The protein was then inverted into a new tube and collected at 1,000xg for 2 
minutes at room temperature.  Total protein was analyzed by BCA assay (Thermo 
Scientific), and 10 μg protein was loaded into each lane of a 10% Mini-Protean TGX 
precast gel (Bio-rad, Hercules, CA).  Following western transfer, the PVDF membranes 
were blocked for 1 hour in 5% Milk in TBST (Tris Buffered Saline with 0.05% Tween-
20) and incubated overnight at 4oC in rabbit anti-cAMP protein kinase catalytic subunit 
antibody (Abcam, 1:3000), rabbit anti-pERK1/2 antibody (Cell Signaling Technology, 
1:400) or rabbit anti-ERK1/2 (Cell Signaling Technology, 1:1000) diluted in blocking 
buffer. After rinsing, the blots were incubated for 1 hour at room temperature in goat-anti 
rabbit HRP antibody (Santa Cruz Biotechnology, 1:1000).  The signal was developed 
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using SuperSignal West Pico Substrate (Thermo Scientific) as directed by the 
manufacturer, and images were obtained with a FluorChem HD2 digital imager (Protein 
Simple, Santa Clara, CA).   Band intensity was calculated and analyzed using AlphaView 
software (Protein Simple).  The data represent the results of protein isolated from at least 
three independent experiments.  
4.2.9.  Histology and Immunostaining 
EBs were fixed with 4% buffered formalin, rinsed in PBS, and resuspended in 
OCT solution (Thermo Scientific) for cryosectioning.  Frozen sections (10 μm) were 
rehydrated for 10 minutes in PBS.  Prussian Blue staining was performed to locate the 
beads within the EBs.  The sections were incubated in a 1:1 solution of 20% aqueous 
hydrochloric acid: 10% aqueous potassium ferrocyanide for 20 minutes at room 
temperature.  Following three rinses in distilled water, the slides were counterstained in 
Nuclear Fast Red (Sigma-Aldrich) for 5 minutes at room temperature.  The slides were 
rinsed twice in distilled water, cleared and mounted with Cytoseal (Thermo Scientific). 
For immunostaining, epitope retrieval was performed using 0.25% trypsin 
solution (Thermo Scientific) for 20 minutes at 37oC in a humidified chamber.  To detect 
intracellular protein, samples were permeabilized in 0.5% Triton-X in PBS for 10 
minutes at room temperature.  After rinsing, sections were blocked for 1 hour at room 
temperature in 10% normal goat serum (NGS) or normal donkey serum (NDS).  The 
samples were incubated overnight at 4oC in rat anti-integrin β1 (Abcam, Cambridge, MA, 
1:100 in 1% NDS), mouse anti-sarcomeric α-actin (5c5, Sigma Aldrich, 1:500 in 1% 
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NGS) or rabbit anti-connexin 43 (CX 43, Cell Signaling Technologies, 1:250 in 1% 
NGS).  The sections were rinsed in TBST and incubated in goat anti-mouse IgM FITC 
(Abcam, 1:100 in 1% NGS), goat anti-rabbit Alexa Fluor 488 (Invitrogen, 1:500 in 1% 
NGS) or donkey anti-rat Alexa Fluor 594 (Invitrogen, 1:500 in 1% NDS) for 1 hour at 
room temperature.  The samples were counterstained with 5 μg/ml 4',6-diamidino-2-
phenylindole (DAPI, Life Technologies) for 15 minutes and mounted with Prolong Gold 
antifade reagent (Life Technologies).  Beta 1 integrin images were taken using a Leica 
DMI2000B microscope with a Leica DFC290 camera.  CX 43 and sarcomeric α-actin 
images were taken using a Zeiss scanning confocal microscope. 
4.2.10.  Statistics 
Statistical analysis was performed using StatPlus LE software (AnalystSoft).  All 
groups analyzed represent three independent experiments.  Data from each of the groups 
was compared using one-way ANOVA coupled with Tukey’s Post Hoc test.  Values are 
reported as mean ± standard deviation unless indicated otherwise.  p-values less than 0.05 
were considered statistically significant. 
4.3.  RESULTS 
4.3.1.  Paramagnetic beads do not affect EB morphology 
To prepare the EBs, we used Aggrewell 400TM plates to aggregate the ESCs and 
also facilitate bead incorporation within the aggregate.  By FACS analysis, we calculated 
that the approximate number of beads loaded into each EB was 500 beads/EB (data not 
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shown).  We confirmed the bead incorporation procedure by light microscopy and 
Prussian Blue staining on sectioned EBs, in which the latter stains ferric ions a blue color.  
In comparison to the control EBs with no beads (Figure 4.1 A, A’), the EBs with the 
magnetic beads were darker in light micrographs (Figure 4.1B), and the beads appeared 
distributed throughout the entire EB (Figure 4.1B’).  To examine the effects of beads or 
magnetization on EB gross morphology, we quantified EB size 24 hours after magnetic 
attraction.  No significant differences were observed regardless of bead incorporation or 
magnetization (Figure 4.1C).  
 4.3.2.  Magnetic field strength proportionally increases force on cells by RGD-
Beads 
In this study, we used RGD-immobilized paramagnetic beads to exert mechanical 
stimuli to cells within the interior of EBs.  As mentioned previously, Uda et al (2011) 
demonstrated that one hour of MTC using RGD-beads decreased pluripotency markers in 
mESCs (Uda et al., 2011). In this study, we investigated how magnetization at different 
field strengths can affect mechanotransduction in murine EBs. We had previously 
observed that cycling neodymium magnets underneath EBs resulted in a continuous 
attraction of the EBs to the magnets.  In our stimulation regimen, an array of neodymium 
magnets with different thicknesses and field strengths were placed on an orbital shaker at 
37oC/5%CO2 (Figure 4.2A).  These magnets were cycled at 42 rpm one quarter inch 
underneath an immobilized Aggrewell plate, which allowed us to exert a continuous 
magnetic field while minimizing fluid shear forces on the cells.  
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For our magnetic attraction experiments, we compared three types of neodymium 
magnets with different magnetic field strengths: ¾” x ⅛” N42 neodymium magnets, ¾” x 
¼” N42 neodymium magnets, and ¾” x ½” N42 neodymium magnets (K&J Magnetics).  
Using a gaussmeter, we calculated that the magnetic field strengths were 0.128 Tesla, 0.2 
Tesla and 0.4 Tesla respectively with the EBs placed one-quarter inch above the magnets.  
To model the force acting on the EBs, the cycle of magnet rotation was divided into 126 
frames using a customized Matlab program (Mathworks, Natick, MA) where each frame 
differs by 0.05 radians.  At every frame, the magnetic field at each position was modeled.  
The force (𝐹) acting on each point within the wells was calculated using  𝐹 = !!∆!!! 𝐵 ∙ ∇ 𝐵  (1) 
where B is the magnetic field, vm is the total volume of the magnetic material, Δx is the 
effective magnetic susceptibility of the RGD-Bead attached to the cell and μ0 is the 
magnetic constant in a classical vacuum as described previously (Zborowski, Sun, 
Moore, Stephen Williams, & Chalmers, 1999). The magnitude of force applied to the 
cells during magnetization was summarized for each of the points and averaged for each 
Aggrewell over 1 minute (42 cycles).  From these calculations, we approximated that the 
force exerted on the cells was 10 piconewton (pN) at 0.128 Tesla (Figure 4.2B), 20 pN at 
0.2 Tesla (Figure 4.2C), and 80pN at 0.4 Tesla (Figure 4.2D). 
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4.3.3.  High field strengths negatively affect short term but not long term viability 
We next sought to determine whether there was any negative effect of magnetic 
attraction on cell viability.  We performed live/dead staining on the EBs 24 hours 
following stimulation to examine any effects on immediate cytotoxicity, as well as on 
Day 7 to compare effects on long-term viability.  After 24 hours, there was no difference 
in the number of dead cells within the EBs containing RGD-Beads maintained under 
static conditions (Figure 4.3A), 0.128 Tesla (Figure 4.3B) or 0.2 Tesla magnetic fields 
(Figure 4.3C); however, more dead cells were stained in EBs exposed to a 0.4 Tesla 
magnetic field (Figure 4.3D).  In contrast, there was no evident effect of magnetic field 
strength on long-term viability in EBs with RGD-Beads (Figure 4.3A’-D’).  No effect on 
viability was observed in EBs containing AcLDL-Beads, which do not bind to integrins, 
or EBs without beads at any of the field strengths tested (Figure 4.4).  
4.3.4.  Mechanotransduction in EBs in response to magnetization 
Integrins have been well established to play an integral role in the transmission of 
mechanical signals in cells (Matthews, Overby, Mannix, & Ingber, 2006), and their 
manipulation via mechanical forces has been observed to increase small molecule 
expression and subsequent activation of a variety of signaling cascades (Alenghat, Tytell, 
Thodeti, Derrien, & Ingber, 2009; Laboureau et al., 2004). In response to mechanical 
stress, cAMP levels increase, subsequently activating cAMP protein kinase (Protein 
Kinase A, PKA) (Bukoreshtliev, Haase, & Pelling, 2013; Meyer et al., 2000). In this 
study, we investigated the effects of magnetically mediated strain on PKA levels in EBs.  
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As a negative control, we also incorporated AcLDL-beads within EBs, which is a 
standard control for MTC because they do not specifically bind integrin (N. Wang et al., 
1993).  
In the absence of magnetic attraction, PKA expression was observed in all 
samples regardless of the presence of RGD- or AcLDL-Beads (Figure 4.5A,E).  
Following one hour of exposure to a 0.128 Tesla field, there was no difference in the 
amount of PKA observed between samples (Figure 4.5B,F).  As the field strength 
increased to 0.2 Tesla, significant differences in PKA expression could be observed 
between groups.  While there was no difference in PKA between controls and AcLDL-
Bead groups, levels increased approximately 6-fold in EBs containing RGD-Beads 
(Figure 4.5C,G).  As the field strength increased to 0.4 Tesla, PKA levels decreased to 
the level of the unloaded and AcLDL-Bead controls (Figure 4.5D,H). 
To further verify that the increases in PKA were the result of integrin activation 
by RGD-Beads, we examined the effects of magnetization on β1 integrin expression and 
blocking by GRGDS.  Positive β1 integrin immunostaining was observed in EBs 
containing both AcLDL- and RGD-Beads (Figure 4.5I,J).  Following GRGDS inhibition, 
PKA levels were decreased in magnetized samples containing RGD-Beads (Figure 4.5K).   
The involvement of β1 integrin was also verified by PKA levels in AcLDL-Bead 
containing EBs: there was no change in PKA expression between static and magnetized 
groups. 
Since the onset of mechanical stimulation can have different effects on ESC 
differentiation (Geuss & Suggs, 2013), we also investigated how the timing of magnetic 
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mediated stress affects mechanotransduction in EBs.  Regardless of whether stimulation 
was initiated on Day 1 (Figure 4.6A), Day 2 (Figure 4.6B) or Day 3 (Figure 4.6C), the 
expression of pERK1/2, whose expression is correlated to integrin activation (Laboureau 
et al., 2004; Offenberg Sweeney et al., 2004), was significantly increased following 
magnetic attraction.  PKA expression was also significantly increased in Day 1 and 3 
samples (Figure 4.6A,C).  These results demonstrate that EBs can sense and respond to 
mechanical stress throughout the earliest stages of differentiation. 
4.3.5.  Timing of stimulation affects cardiomyogenesis in EBs 
Based on our observation that EBs are able to respond to mechanical signals at 
different timepoints (Figure 4.6), we sought to examine the effect of attraction timing on 
differentiation.  ESC differentiation into cardiomyocytes has been observed following 
exposure to multiple types of mechanical stimuli, including shear (Wan et al., 2011) and 
cyclic (Gwak et al., 2008; Salameh et al., 2010; Shimizu et al., 2008) forces; however, the 
effect of magnetic attraction on cardiomyogenesis from pluripotent cells has not yet been 
investigated.  To investigate the effect of magnetically mediated strain on ESC 
differentiation, we exposed the EBs to a 0.2 Tesla magnetic field, as this strain magnitude 
most effectively increased PKA expression while maintaining cell viability (Figures 4.3, 
4.4, 4.5).  EBs were stimulated for 1 hour on Day 1, Day 2 or Day 3.  Since BMP4 
supplementation is currently the most effective regimen for differentiating mouse ESCs 
into cardiomyocytes (Taha & Valojerdi, 2008), we also compared the combinatorial 
effects of BMP4 and mechanical stimulation (Figure 4.7A).   
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Stimulation of early EBs, specifically on Day 1 (Figure 4.7B) or Day 2 (Figure 
4.7C), did not appear to have any significant effect on cardiomyocyte differentiation, as 
the percentage of contractile foci were comparable to controls with or without BMP4 
supplementation.  When BMP4 was added to the medium during suspension culture, Day 
3-stimulated EBs (Figure 4.7D) containing the RGD-Beads had significantly higher 
percentages of contractile foci compared to controls by Day 17 (33%±14% versus 
4%±7%).  The presence of beads alone also appeared to have an effect on contractile 
activity compared to controls; however, only AcLDL-Bead-containing EBs had 
significantly higher levels than controls (18%±8%).  These trends were not observed 
when BMP4 was omitted from the medium (Figure 4.7D). 
Considering the difference in contractile activity, we further examined the 
expression of sarcomeric α-actin within the Day 3-stimulated EBs on Day 18 by FACS 
analysis and immunostaining.  For the former, in the presence of BMP4 there was a shift 
in fluorescence intensity in all EBs (Figure 4.8B) compared to those which were not 
exposed to BMP4 (Figure 4.8A).  In the absence of BMP4, there were no significant 
differences between the control and EBs containing either AcLDL-Beads or RGD-Beads 
(Figure 4.8C).  With BMP4 added to the medium, there were significantly more 
sarcomeric α-actin positive cells in stimulated EBs containing RGD-Beads 
(33.2%±3.8%) compared to unloaded controls (22.0%±1.1%)(Figure 4.8D).  Connexin 
43 (Figure 4.8E) and sarcomeric α-actin (Figure 4.8F) immunostaining was observed 
sections of Day 18 EBs released from gelatin-coated plastic.  Expression was observed in 
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the vicinity of beads (labeled as “b”), which could not be observed directly by confocal 
microscopy but appeared as a shadow in the micrographs. 
4.4.  DISCUSSION 
In this study, we developed a unique method to expose a larger population of 
ESCs within an EB to mechanical strain.  We demonstrated that RGD-Beads, such as 
those used for MTC, can be incorporated into the interior of the EB and bind to cells 
within that EB.  By adjusting the thickness of the magnets, and consequently the 
magnetic field strength, we can take advantage of the RGD-integrin interactions to induce 
strain on the individual cells without compromising viability.  A complication that occurs 
with current mechanical stimulation regimens is that ESCs experience non-uniform 
forces, which produce the same heterogeneous cell population that would occur naturally 
without stimulation.  Immobilization of RGD-Beads within the EB interior has the 
potential to reduce this variability.  In addition, this process does not impact 
differentiation protocols that would depend on suspension culture during downstream 
processing.   
A benefit of this mechanical stimulation regimen is that it is a cost-effective 
method to present a permanent magnetic field to cells in culture.  The magnetic field 
strength can be easily adjusted by altering the strength of the neodymium magnets, and 
the force acting on the cells in response to magnetization can be deduced using the 
equation developed by Zborowski et al (1999) for a magnetized cell in a quadripole field 
(Equation 1) (Zborowski et al., 1999). Overall, our results confirm previous findings that 
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ESCs are responsive to integrin-mediated forces, and these forces lead to outside-in 
signaling cascades that can direct cell fate (Chowdhury et al., 2009; Uda et al., 2011). 
These forces can be assessed by the expression of small molecules and proteins, such as 
PKA and pERK1/2, which are well established to be directly regulated by mechanical 
stimulation (Figures 4.5, 4.6) (Alenghat et al., 2009; Laboureau et al., 2004; Meyer et al., 
2000). Consequently, the same methods that are used to study mechanical signal 
transmission in differentiated cells can be applied to pluripotent stem cells. 
In general, there is limited information about the amount of force required by cells 
to activate signaling or respond to external stress.  This has been most recently addressed 
by Wang et al (2013), whom have developed a Tension Gauge Tether (TGT) technique to 
quantify the amount of force required to activate integrin and Notch signaling cascades in 
immortalized CHO cells (X. Wang & Ha, 2013). The authors reported that Notch 
signaling was activated by less than 12 pN force, and that cells apply approximately 40 
pN force to single integrin-ligand adhesions.  Forces above 40 pN result in stress fiber 
formation in vitro.  Based on our model, 0.2 Tesla magnetic fields exert approximately 20 
pN force on the ESCs.  Doubling the magnetic field to 0.4 Tesla exerts almost 80 pN 
force, which negatively affects signal transduction and viability.  While we would predict 
that 20 pN would be too low to transmit mechanical signals, our results suggest that this 
magnitude is sufficient to activate integrins.  There are a few possible explanations for 
this discrepancy: (1) there may be differences in force sensitivity between differentiated 
and pluripotent stem cells or (2) there may be other forces experienced by the cells within 
the EB, such as shear forces between cells, that are not adequately represented by either 
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model.  In the future, a better understanding of the range of forces and force strengths 
being experienced during ESC aggregation may clarify these questions. 
Cell-matrix interactions, and their manipulation, have been widely observed to 
play important roles in directing pluripotent cell fate (Battista et al., 2005; Brafman, 
Phung, Kumar, & Willert, 2013; Chowdhury et al., 2009; Dawson et al., 2011; Pimton et 
al., 2011; Yanada et al., 2006). Considering mechanical stimulation can direct 
cardiomyogenesis from pluripotent cells (Geuss & Suggs, 2013), we asked whether 
magnetic attraction can similarly direct differentiation.  Timing the onset of mechanical 
stimulation can have drastic effects on fate determination in regards to cardiovascular 
phenotypes.  While short term applications of cyclic strain between days 4 and 7 during 
EB development increase the percentage of differentiated cardiomyocytes (Gwak et al., 
2008; Heo & Lee, 2011; Schmelter et al., 2006), early and prolonged exposure maintains 
pluripotency (Saha, Ji, de Pablo, & Palecek, 2006; 2008). Our results similarly suggest 
that cardiomyogenesis in EBs is most effective when mechanical stimulation is initiated 
later during EB development, around Day 3.  This was made evident by maintained 
contractile activity at Day 17 and significantly increased sarcomeric α-actin expression 
(Figures 4.7, 4.8).  Interestingly, this is only observed when BMP4, which is the most 
effective morphogen for mESC differentiation into cardiomyocytes, is supplemented to 
culture medium. Considering that Brachyury expression, a marker for mesendoderm 
(Kattman, Huber, & Keller, 2006), peaks around Day 3 and 4 of EB development 
(Boheler et al., 2002; Bratt-Leal, Nguyen, Hammersmith, Singh, & Mcdevitt, 2013; Czyz 
& Wobus, 2001), this would suggest that pre-differentiation of EBs towards mesodermal 
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fates prior to the onset of mechanical stimulation is optimal for cardiomyogenesis in 
vitro.  Therefore, while mechanical stimulation by magnetization is alone not sufficient to 
drive differentiation, it can be combined with other protocols to enhance cardiomyocyte 
differentiation. 
To date, there are few studies that have been able to investigate the effects of 
early mechanical stimulation on the terminal phenotype of ESCs.  Often this issue is due 
to logistics: there is a minimum amount of time required to allow EBs to attach to culture 
surfaces and also acclimate to new environments prior to exposure to stress.  While this 
study primarily focused on cardiomyocyte differentiation, earlier exposure to 
magnetization (Days 1-2) may be driving differentiation into other phenotypes.  This is 
suggested by preliminary data, in which EBs magnetized on Day 1 express significantly 
less SSEA-1, a marker for mouse ESC pluripotency, by Day 7 compared to EBs 
stimulated on Day 2 or 3 (data not shown).  Further investigation into the effects of 
integrin-RGD interactions, and how they change during the first few days of EB 
differentiation, will be useful for tailoring magnetic attraction to derive specific 
differentiated cells. 
4.5.  CONCLUSIONS 
Our data showed that magnetically mediated strain applied by RGD-immobilized 
paramagnetic beads activates mechanochemical signaling in murine EBs.  We also 
observed that ESC response to strain is dependent on the magnetic field strength, as high 
field strengths can apply too much force on the cells, resulting in cell death.  
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Magnetically mediated strain can also be used to direct differentiation of mESCs into 
cardiomyocytes; however guiding the mesodermal commitment of mESCs prior to the 
onset of stimulation is required.  Conceivably, this system may be tailored to derive other 
cell types that are similarly influenced by mechanical forces by altering the medium 
supplements and timing accordingly. 
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Figure 4.1:  Gross morphology of EBs with immobilized beads.  Bead incorporation was 
confirmed by light micrographs (A-B) and Prussian Blue staining (A’-B’).  
(C) Size comparison of EBs with or without magnetization.  Arrows indicate 
location of beads within EB.  Scale: 100 μm. 
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Figure 4.2: Magnetic attraction apparatus setup. (A) An array of N42 permanent 
neodymium magnets with different thicknesses were arranged on an orbital 
shaker. The force applied to the cells was modeled using a customized 
Matlab program over the course of 1 min (42 cycles) at 0.128 Tesla (B), 0.2 
Tesla (C), and 0.4 Tesla (D).   
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Figure 4.3: Live/dead analysis of EBs containing RGD-Beads following magnetization.  
Live/dead was analyzed by confocal microscopy 24 hours after magnetic 
attraction (A-D) or 6 days after magnetic attraction (A’-D’). Scale bar: 100 
μm. 
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Figure 4.4: Live/dead imaging of EBs with or without AcLDL-Beads. Live cells (green) 
and dead cells (red) were observed in controls and EBs with AcLDL-beads 
24 hours after magnetization and 6 days after magnetization on Day 1. Scale 
= 100 μm. 
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Figure 4.5: Second messenger marker expression in response to magnetic attraction. EBs 
incubated in static conditions (A,E) were compared to EBs exposed to 0.128 
Tesla magnetic fields (B,F), 0.2 Tesla magnetic fields (C,G) and 0.4 Tesla 
magnetic fields (D,H). (A-D) Representative western blots under each 
condition. (E-H) Normalized PKA expression relative to ERK. (I) β1 
integrin immunostaining in EBs with AcLDL-Beads and (J) RGD-Beads 24 
hours following stimulation at 0.2 Tesla. Scale = 20 μm. (K) Effect of β1 
integrin inhibition by GRGDS on PKA expression. C: control, AB: AcLDL-
Beads, RB: RGD-Beads. *p<0.05 
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Figure 4.6: Expression of PKA and phosphorylated ERK1/2 in response to magnetic 
attraction at different stages of EB development.  Western blot analysis of 
EBs stimulated on Day 1 (A), Day 2 (B) or Day 3 (C). Protein expression 
was normalized to ERK. MS: mechanical stimulation, C: control, RB: RGD-
Beads. * p<0.05.  
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Figure 4.7: Percentage of EBs with contractile areas on Day 17. (A) Timeline of EB 
mechanical stimulation and culture. BMP4 (10 ng/ml) was added between 
Days 1-7. EBs were stimulated on Day 1 (B), Day 2 (C), or Day 3 (D) in the 
presence or absence of BMP4. MS: mechanical stimulation. * p<0.05. 
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Figure 4.8: Sarcomeric α-actin expression in Day 3-stimulated EBs.  Histogram 
representation of sarcomeric α-actin+ cells in Day 18 EBs without BMP4 
(A) and with BMP4 (B). (C-D) Percent of sarcomeric α-actin cells in EBs 
without (C) and with (D) BMP4 supplementation. (E) Cx43 and (F) 
sarcomeric α-actin immunostaining of Day 3-stimulated EBs on Day 18. 
“b”: location of beads within confocal micrograph. AB: AcLDL-Beads, RB: 
RGD-Beads, M: magnetized. *p<0.05. Scale bar: 20 μm. 
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CHAPTER FIVE 
Effect of PEGylated fibrin gel stiffness on HL-1 and mouse ESC-derived 
cardiomyocyte maintenance and maturity 
Cell transplantation into the damaged myocardium, or cellular cardiomyoplasty, 
has the potential to promote myocardium regeneration after Myocardial Infarction (MI); 
however, this strategy is limited due to cell loss shortly after injection.  To address this 
limitation, cells can be incorporated into a compliant matrix, which can physically 
encapsulate the cells into the host tissue.  Encapsulating the cells inside a matrix provides 
time for cells to remodel their environment by depositing extracellular matrix and 
electrically coupling with the host tissue.  PEGylated fibrin gels are biocompatible, with 
controllable degradation rates, and have been shown to promote neovascularization and 
mesenchymal stem cell (MSC) retention in the myocardium.  We investigated if 
PEGylated fibrin gels can promote HL-1 cardiomyocyte functionality and mouse 
embryonic stem cell-derived cardiomyocyte (mESC-CM) maturation.  PEGylated fibrin 
gels were prepared at concentrations ranging from 10 mg/ml to 25 mg/ml, and 
cardiomyocytes were either incorporated within the interior of the hydrogel (3D) or 
cultured on the surface of the gels (2D).  We observed that regardless of the seeding 
density, HL-1 cardiomyocytes are unable to remodel the 10 mg/ml PEGylated fibrin gels, 
and consequently form non-contractile aggregates.  When HL-1 are cultured on the 
surface of hydrogels, contractile activity is increased on more compliant gels compared to 
stiffer, more concentrated gels.  A 3D-like construct could be fabricated by layering HL-1 
in between 10 mg/ml fibrin gels: in this situation, the addition of PEGylated fibrin gel 
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layers to the cells did not inhibit contractile activity or viability.  To examine the potential 
fibrin gels on mESC-CM maturity, EBs were stimulated using magnetically mediated 
strain as described in Chapter 4.  EBs with contractile areas were dissociated, yielding a 
50% sarcomeric a-actin positive population, and seeded onto 2D PEGylated fibrin gels.  
The mESC-CM and non-cardiomyocytes proliferated to confluency on all of the gels, 
regardless of the stiffness; however, contractile activity was lost due to the high 
concentration of non-cardiomyocytes in the cell suspension.  This study demonstrates that 
PEGylated fibrin gels can be used as MI patches; however, both the initial cell population 
and method of cell seeding must be optimized to promote contractile function. 
5.1.  INTRODUCTION 
Myocardial Infarction (MI), which is one of the most prevalent diseases in the 
United States, results in scar tissue formation and thinning of the myocardial wall 
(Christman et al., 2004).  Since cardiomyocytes are inherently unable to regenerate and 
repopulate the infarcted area, MI can result in permanent tissue damage and is lethal if 
left untreated.  Heart transplants are currently the only option for permanent tissue repair; 
however, there are significant risks associated with this procedure, including tissue 
rejection.   
Cellular cardiomyoplasty, in which viable cells are injected into the injured tissue, 
is being explored as an alternative and less invasive procedure to repair the myocardium.   
This was first observed by Soonpaa et al in 1994, who demonstrated that fetal 
cardiomyocytes could form stable intracardiac grafts when implanted into the 
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myocardium (Soonpa, Koh, Klug, & Field, 1994).  Since then, many other groups have 
investigated the potential of a range of cell types for cellular cardiomyoplasty, including 
fetal cardiomyocytes (Soonpa et al., 1994), skeletal muscle cells (Laflamme, Zbinden, 
Epstein, & Murry, 2007), and stem cells such as mesenchymal stem cells (MSC) (ORLIC 
et al., 2006; J. S. Wang et al., 2000) and pluripotent stem cells (PSC) (Min et al., 2002). 
A drawback to this approach is cell retention in the infarcted area: In a study with 
radioactively labeled endothelial progenitor cells, less than 5% of injected cells remained 
in the myocardium after 96 hours (Aicher et al., 2003). 
Tissue engineering, in which cells are combined with biocompatible materials, is 
an alternative to the direct cell injection method.  The addition of the biomaterial can both 
improve cell viability and increase retention and engraftment at the site of injury (Rask et 
al., 2010).  A variety of methods to incorporate the material into the myocardium have 
been investigated, including patches (Hidalgo-Bastida et al., 2007; Y.-C. Huang, Khait, & 
Birla, 2007; Marsano et al., 2010; Robinson et al., 2005; Smith et al., 2012), cell sheets  
(C.-C. Huang et al., 2010; Matsuura et al., 2011; Sawa & Miyagawa, 2013; Shimizu, 
Sekine, Yamato, & Okano, 2009), and injectable biomaterials (Christman et al., 2004; 
Gerard, Forest, Beauregard, Skuk, & Tremblay, 2012; Johnson & Christman, 2012; 
Shapira-Schweitzer, Habib, Gepstein, & Seliktar, 2009; G. Zhang, Wang, Wang, Zhang, 
& Suggs, 2006).   The combination of cells and the materials significantly decreases 
infarct size, promotes cell viability and ECM deposition.  Cell sheets can be stacked, 
forming a scaffold-free patch that can be implanted onto the myocardial infarct (Shimizu 
et al., 2009). 
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Fibrin-based gels have many advantages for myocardial tissue engineering, 
including biocompatibility and stable degradation in vitro and in vivo (Mosesson, 2005).  
Each Aα chain on fibrinogen molecules have two Arginine-Glycine-Aspartic Acid 
(RGD) sequences, which promotes cell attachment and proliferation (Yang, Wu, 
Asakura, Kohno, & Matsuda, 2004).   While fibrin hydrogels resorb within 7 days in 
vitro (LIU, Collins, & Suggs, 2006), they can be stabilized by conjugating amine-reactive 
polyethylene glycol (PEG) prior to the addition of thrombin producing a PEGylated fibrin 
hydrogel.    We have previously demonstrated that PEGylated fibrin gels incorporated 
with MSCs significantly increases left ventricle ejection fraction function following MI 
by increasing cell retention and reducing scar formation (G. Zhang et al., 2006). In this 
study, we examined the potential of using this PEGylated fibrin gel system to maintain 
cardiomyocytes.  Since scaffold stiffness has been observed to play a critical role in 
cardiomyocyte maturation (Engler et al., 2008; Zoldan et al., 2011), we compared HL-1 
and mESC-CM proliferation, viability, contractile activity, and cardiomyocyte-marker 
expression on PEGylated fibrin gels with different concentrations of fibrinogen.  We 
have observed that fibrinogen concentration does affect cardiomyocyte activity and 
functionality, and function is also dependent on the method of cardiomyocyte 
incorporation into the matrix. 
 111 
5.2.  MATERIALS AND METHODS 
5.2.1.  Embryonic Stem Cell Culture 
R1 mouse ESCs (A. Nagy, Toronto, Canada) were expanded feeder-free on 0.1% 
gelatin-coated cell culture flasks (Stem Cell Technologies, Vancouver, Canada) in 
Growth Medium containing Knockout Dulbecco’s Modified Eagle’s Medium 
(Invitrogen, Grand Island, NY) supplemented with 15% ES-Cult Fetal Bovine Serum 
(Stem Cell Technologies), 1% Glutamax (Invitrogen), 1% Non-Essential Amino Acids 
(Invitrogen), 1% Nucleosides (Millipore, Billerica, MA), 1% Penicillin/Streptomycin 
(Invitrogen), 0.1mM β-Mercaptoethanol (Invitrogen) and 103 U/ml Leukemia Inhibitory 
Factor (LIF; Millipore).  Medium was changed in full each day, and cells were passaged 
every 2 days before reaching approximately 70% confluence. 
5.2.2.  RGD-Bead preparation 
RGD-Beads were prepared as previously described, with a few modifications 
(Ingber, 2006; Laboureau, Dubertret, Lebreton-De Coster, & Coulomb, 2004).  Briefly, 
50 μg Peptite 2000 (Advanced Biomatrix, San Diego, CA) was bound to 1 mg of 1μm 
BcMagTM tosyl-activated paramagnetic beads (Bioclone, San Diego, CA) for 72 hours at 
4oC in 0.1M Carbonate Buffer, pH 9 as suggested by the manufacturer.   The RGD-bound 
beads (RGD-Beads) were rinsed three times in PBS containing calcium and magnesium 
with a Dynal magnet (Invitrogen) and blocked for 1 hour in PBS containing 5% Bovine 
Serum Albumin (Sigma-Aldrich, St. Louis, MO).  Following an additional three rinses in 
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PBS, the beads were resuspended in medium and added to the Aggrewell plates at 1 mg 
beads per well, yielding a final concentration of approximately 500 beads/EB. 
5.2.3.  Differentiation and isolation of mouse embryonic stem cell derived–
cardiomyocytes 
ESCs were enzymatically released from the gelatin-coated plates with 
trypsin/EDTA (ATCC, Manassas, VA) and resuspended in Differentiation Medium 
(Growth Medium without LIF).  Approximately 1.2 million cells were added to each well 
of a 24-well Aggrewell 400TM plate (Stem Cell Technologies) as directed by the 
manufacturer.  The final EB sizes were approximately 1,000 cells/EB.  Once the EBs 
were allowed to settle for 30 minutes at 37oC/5%CO2, the beads were distributed to the 
appropriate wells. The EBs were kept in the Aggrewell 400TM plates for 3 days, and 
medium was partially changed daily.  On Day 3, the EBs were exposed to magnetic 
attraction for 1 hour as described in Chapter 4.  After stimulation, the EBs were 
transferred to suspension culture in ultra-low attachment plates and medium was changed 
in full every 2 days.  BMP4 (10 ng/ml) was added to the culture medium from Days 1 
through 7.  On Day 7, the EBs were allowed to attach to gelatin-coated plates and 
maintained for up to 18 days at 37oC/5%CO2.  Approximately 2-3 EBs were plated per 
well of a 24 well plate. 
After 18 days, contractile EBs were incubated in 0.2% collagenase type I 
(Invitrogen) in DMEM/20% FBS for 1 hour at 37oC/5%CO2.  The collagenase solution 
was then removed and the EBs were incubated for 5-7 minutes in 0.25% trypsin/EDTA 
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(Invitrogen).  The EBs were triturated with a 1000 μl pipet and the single cell suspension 
was neutralized with DMEM/20% FBS and collected by centrifugation for 5 min at 
270xg.   
5.2.4.  HL-1 cardiomyocyte culture 
HL-1 cardiomyocytes, a gift from Dr. William Claycomb, are a cardiac muscle 
cell line from the AT-1 mouse atrial cardiomyocyte tumor lineage (Claycomb et al., 
1998).  These cells are phenotypically and genotypically similar to mature 
cardiomyocytes, in that they maintain contractility and express cardiomyocyte-specific 
genes including α-myosin heavy chain, sarcomeric α-actin and connexin 43.  HL-1 from 
passages 50-60 were maintained in Claycomb medium (Sigma) supplemented with 10% 
Fetal Bovine Serum (Sigma lot# 12J001), 1% Penicillin/Streptomycin (Invitrogen), 1% 
Glutamax (Invitrogen), and 0.1mM Norepinephrine.  The cells were seeded into flasks at 
100,000 cells/cm2, and were split 1:3 every 4 days. 
5.2.5.  PEGylated fibrin gel fabrication 
PEGylated fibrin hydrogels were prepared as previously described, with a few 
modifications (G. Zhang, Drinnan, Geuss, & Suggs, 2010).  Human fibrinogen (Sigma) 
was solubilized in PBS (pH 7.8, without calcium and magnesium) at 40 mg/ml, 60 
mg/ml, 80 mg/ml and 100 mg/ml.  To increase gel stability, homo-bifunctional 
Succinimidyl Glutarate-Polyethylene Glycol (SG-PEG-SG) was similarly solubilized in 
PBS at 4 mg/ml, 6 mg/ml, 8 mg/ml and 10 mg/ml.  These concentrations correspond to a 
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10:1 molar ratio of fibrinogen to PEG for final concentrations of 10 mg/ml fibrinogen + 1 
mg/ml PEG, 15 mg/ml fibrinogen + 1.5 mg/ml PEG, 20 mg/ml fibrinogen + 2 mg/ml 
PEG and 25 mg/ml fibrinogen + 2.5 mg/ml PEG, respectively.  Human thrombin (Sigma) 
was diluted to 100 U/ml in nanopure water and further resuspended in 40 mM calcium 
chloride buffer for a final concentration of 25 U/ml.  All solutions were sterile-filtered 
through a 0.22 μm filter prior to incubation with cells. The volumes of each of the 
components used are listed in Table 5.1. 
For long-term 3D studies, 500 μl gels were prepared in CellCrownTM 12-well 
plate inserts (Sigma).  HL-1 cardiomyocytes were suspended within the gel at final 
concentrations of 1 Million/ml, 2.5 Million/ml or 5 Million/ml.  After 24 hours, the gels 
were transferred to ultralow attachment 6-well plates containing 5 ml medium.  Medium 
was changed in full every 2 days.   
For 2D experiments, 750 μl gels were formed without cells in 35mm glass-bottom 
petri dishes.  After a 2-hour incubation in medium, cardiomyocytes were added to the 
surface of each hydrogel at 105 cells/cm2.  For 2D layer (2DL) gels, an additional 500 μl 
10 mg/ml gel was prepared on top of the confluent cardiomyocyte monolayer after 4 days 
in culture.  For 2DL experiments, only 10 mg/ml fibrinogen + 1 mg/ml PEG hydrogels 
were tested.  Medium was changed daily over the course of 7 days. 
5.2.6.  Rheology 
PEGylated fibrin gels were prepared as described in section 5.2.5.  A 2-ml layer 
of 10 mg/ml fibrinogen, 15 mg/ml fibrinogen, 20 mg/ml fibrinogen and 25 mg/ml 
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fibrinogen was prepared in 6-well plates with 500 μl fibrinogen, 500 μl PEG and 1 ml 
thrombin.  The gels were incubated at 37oC/5%CO2 for 2 hours, and samples were 
collected from the layers using a 40mm diameter punch.   The frequency sweep was 
measured at 1% from 20 to 0.5 rad/sec.  All samples were measured at room temperature. 
5.2.7.  Cell viability 
HL-1 and ESC-CM viability were assessed using Calcein-AM (Life 
Technologies) and Alamar Blue (Life Technologies).  For Alamar Blue, cells were 
incubated in a 1:10 dilution of Alamar Blue reagent in cell culture medium for 1.5 hours 
at 37oC/5%CO2 and fluorescence was read at 560ex/590em.  For Calcein-AM imaging, 
the cells were rinsed 3 times for 5 minutes with PBS containing calcium and magnesium.  
Calcein-AM (4 μM in PBS containing calcium and magnesium) was added to the cells 
and incubated for one hour at 37oC/5% CO2 in the dark.  After three rinses in PBS, the 
cells were fixed in 4% paraformaldehyde for 15 minutes, rinsed again, and imaged using 
a Zeiss scanning confocal microscope. 
5.2.8.  Detection of contractile activity in HL-1  
HL-1 Contractile activity was observed 3 days after seeding on hydrogels.  
Calcium sensitive Fluo-4 AM (10 mM in dimethyl sulfoxide, excitation/emission 
494/516nm, Life Technologies) was diluted to 10 μM in HL-1 medium.  After 3 rinses in 
PBS, the gels were incubated in diluted Fluo-4 for 30 minutes at room temperature in the 
dark.  To allow for de-esterification of Fluo-4, the gels were rinsed three times in 
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Tyrode’s solution (1.33 mM CaCl2, 1 mM MgCl2, 5.4 mM KCl, 135 mM NaCl, and 0.33 
mM Na2H2PO4) containing 5 mM glucose, 5 mM HEPES and 10 mM norepinephrine.  
The gels were incubated in Tyrode’s solution for another 20 minutes at room 
temperature, and imaged by confocal microscopy within 2 hours as described previously 
with a few modifications (Mihic et al., 2014; Smith et al., 2012).  Briefly, time-lapse 
images were taken at 195 msec intervals for 100 cycles at 128x128 pixels.  A Z-plot 
profile was developed for three separate regions of interest (ROI) using Fiji image 
analysis software, and the fluorescence intensity over time (F0) was normalized to the 
lowest intensity values (Fmin) and plotted as F0/Fmin. 
5.2.9.  Immunostaining 
To visualize sarcomeric α-actin staining and connexin 43 (cx43) staining patterns, 
HL-1 cardiomyocytes or mESC-CM were rinsed with PBS and fixed for 15 minutes with 
4% paraformaldehyde.  For intracellular staining, the cells were permeabilized with 
0.25% Triton-X/PBS for 30 minutes at room temperature.  Following three rinses in PBS, 
the samples were blocked in 10% normal goat serum for 1 hour, and incubated overnight 
in anti-mouse sarcomeric α-actin (5c5, 1:500 in 1% normal goat serum, Sigma Aldrich) 
or anti-rabbit connexin 43 (1:100 in 1% normal goat serum, Cell Signaling Technologies) 
at 4oC.   The cells were rinsed again three times in TBST (Tris Buffered Saline + 1% 
Tween-20) and incubated in goat anti-mouse FITC IgM (1:200 in 1% normal goat serum, 
Santa Cruz Biotechnology) or goat anti-rabbit Alexa Fluor 488 IgG (1:500 in 1% normal 
goat serum, Abcam) for one hour at room temperature in the dark.  The cells were 
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counterstained with 5 μg/ml 4',6-diamidino-2-phenylindole (DAPI, Life Technologies), 
rinsed and imaged using a Zeiss scanning confocal microscope. 
5.3.  RESULTS 
5.3.1.  Rheology 
 The viscoelastic properties of PEGylated fibrin gels with fibrinogen 
concentrations ranging from 10 to 25 mg/ml were assessed by rheology (Figure 5.1A).  
Increases in storage modulus were observed as the concentration of fibrinogen and PEG 
increased (Figure 5.1B).  The storage moduli of the 10 mg/ml, 15 mg/ml, 20 mg/ml and 
25 mg/ml PEGylated fibrin gels were 123.5 ± 29.6, 464.7 ± 77.3, 904.7 ± 71.3 and 966.8 
± 85.5 Pa respectively.  No significant differences between the loss moduli were 
observed. 
5.3.2.  Effect of PEGylated fibrin matrix on 3D HL-1 cardiomyocyte culture 
PEGylated fibrin hydrogels have been shown to effectively promote 
differentiation of both embryonic stem cells (LIU et al., 2006; Shapira-Schweitzer et al., 
2009) and mesenchymal stem cells (G. Zhang et al., 2010) into cardiomyocytes and 
endothelial cells, respectively.  In this study, we investigated the long-term effect of 
homo-bifunctional PEGylated fibrin hydrogels on HL-1 cardiomyocytes as a potential MI 
injectable patch.  The HL-1 were maintained at three different seeding densities in 10 
mg/ml PEGylated fibrin gels: 1 Million/ml, 2.5 Million/ml and 5 Million/ml.  At all three 
concentrations, after 10 days in culture, the HL-1 cardiomyocytes formed cardiosphere-
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like aggregates (Figure 5.2A).  By day 35, these aggregates increased in size such that 
they could be observed by eye (Figure 5.2B).  Alamar Blue (Figure 5.2C) and PCNA 
staining (Figure 5.2D) confirmed that the HL-1 cells within these aggregates were 
proliferative, and maintained the expression of connexin 43 and sarcomeric α-actin 
(Figure 5.2F) 
While the HL-1 did appear to be metabolically active over the course of the 
culture period (Figure 5.2C,D), contractile behavior was not maintained within the 
hydrogels. To further examine the effect of 3D HL-1 culture on cell functional behavior, 
the cells were incubated with Fluo-4 to track changes in calcium concentrations within 
the aggregates.  Calcium transients were observed through the aggregate (Figure 5.2E), 
indicating that the cells were forming gap-junctions; however, calcium cycles were long 
in duration and highly variable.   
5.3.3.  Effect of fibrinogen concentration on HL-1 viability in 2D culture 
Since 3D culture of HL-1 appeared to impair functional activity, we examined the 
effect of (1) culturing the HL-1 on top of PEGylated fibrin gels and (2) the concentration 
of fibrinogen on HL-1 activity.  PEGylated fibrin gels were prepared with final 
fibrinogen concentrations of 10 mg/ml, 15 mg/ml, 20 mg/ml and 25 mg/ml.  The 
fibrinogen:PEG ratio was kept constant at 10:1 for each concentration (Figure 5.3A).  
Cell viability was monitored over 14 days by Alamar Blue.  Regardless of the fibrinogen 
concentration, there was no difference in cell number between groups over the culture 
period (Figure 5.3B).   
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5.3.4.  Effect of PEGylated fibrin concentration on HL-1 viability and morphology 
Considering that scaffold stiffness has been well demonstrated to impact 
cardiomyocyte functional activity in vitro (Engler et al., 2008; Shapira-Schweitzer & 
Seliktar, 2007; Young & Engler, 2011), we examined the effects of 2D PEGylated fibrin 
gels on the maintenance of cardiomyocyte-specific marker expression.  The HL-1 were 
seeded on top of PEGylated fibrin gels prepared at each fibrinogen concentration (Figure 
5.4A,E,I,M).  As the concentration of fibrinogen increased, HL-1 cardiomyocytes spread 
less over the surface of the gel (Figure 5.4A, M); however, there were no evident 
differences in viability (Figure 5.4B,F,J,N).  CX 43 (Figure 5.4C,G,K,O) and sarcomeric 
α-actin (Figure 5.4D,H,L,P) staining was observed in all samples . 
5.3.5.  Effect of fibrinogen concentration on HL-1 contractile activity 
While we previously observed that incorporation of HL-1 into the interior of 
PEGylated fibrin gels impairs contractile activity, we next examined the effect of seeding 
the cells directly on top of the gels in a 2D culture system.  Contractile activity was 
observed in HL-1 by Day 3, and the cells continued to contract through Day 7. During 
cell contractions, the Fluo-4 GFP intensity increased as calcium was passed through the 
cells.  Over three separate ROI, the HL-1 with the most consistent contractile activity 
were those seeded on the 10 mg/ml PEGylated fibrin gels, with cell contractions, or 
calcium peaks, occurring every 0.975 seconds (Figure 5.5A).  These contractions were 
significantly more frequent compared to other PEGylated fibrin gels (Figure 5.5E).  As 
the concentration of fibrinogen increased to 15 mg/ml, the contractions were less 
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consistent and also less frequent: cells contacted every 1.170±0.195 seconds (Figure 
5.5B).  At the highest fibrinogen formulations, 20 mg/ml (Figure 5.5C) and 25 mg/ml 
(Figure 5.5D), the Fluo-4 intensity duration was lowest, at 1.14±0.113 and 1.300±0.113 
seconds, respectively. 
5.3.6.  Effect of PEGylated fibrin gel layers on HL-1 activity 
Considering cardiomyocyte activity is enhanced when seeded on 2D PEGylated 
fibrin surfaces, we investigated how activity is affected when HL-1 are cultured within 
gel layers (2DL).  For these experiments, HL-1 were seeded onto 10 mg/ml 2DL and 
maintained for 4 days in vitro.  On Day 4, an additional gel layer was added on top of the 
cells.  After 24 hours, contractile activity and cardiomyocyte-specific marker expression 
was assessed.  Following addition of the gel layer, the cells appeared completely 
confluent (Figure 5.6A), remained viable (Figure 5.6B) and maintained expression of 
sarcomeric α-actin (Figure 5.6C) and connexin 43 (Figure 5.6D).  Calcium cycle duration 
was decreased in comparison to 2D gels: HL-1 contracted approximately every 1.17 
seconds, which was comparable to that observed on 2D 15 mg/ml gels (Figure 5.6E,F, 
Figure 5.5B), but significantly higher than on 2D 10 mg/ml gels (Figure 5.6F).  In 
comparison, calcium cycle duration was significantly higher in 3D gels, occurring 
approximately every 4.8 seconds (Figure 5.6F). 
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5.3.7.  Effect of fibrinogen concentration on mESC-CM maintenance 
Since PEGylated fibrin gels appeared sufficient to maintain cardiomyocyte 
functionality, we next asked whether these fibrin gels could also be used to maintain 
ESC-CM.  To isolate ESC-CM, EBs with contracting areas were isolated from gelatin-
coated well plates and the sarcomeric α-actin population was analyzed.  From EBs with 
contracting areas, approximately 48% of the cell population were sarcomeric α-actin 
positive (ESC-CM) (Figure 5.7).  
Recent work has demonstrated that embryonic cardiomyocytes are best 
maintained on matrices with stiffness that mimic the heart, between approximately 1-11 
kPa, as opposed to softer substrates (Engler et al., 2008).  Considering our findings that 
matrix stiffness is proportional to fibrinogen concentrations in PEGylated hydrogels, we 
examined the effect of fibrinogen concentration on the maintenance of mESC-CM.  Cell 
morphology and viability were compared for both cell types 6 days after seeding onto gel 
layers ranging from 10 mg/ml to 25 mg/ml (Figure 5.8). Regardless of the gel 
formulation, the differentiated cells from contractile EBs became fully confluent (Figure 
5.8A,D,G,J) and remained viable (Figure 5.8B,E,H,K) regardless of the gel formulation.   
On 20 mg/ml and 25 mg/ml fibrin gels, sarcomeric α-actin appeared aligned and 
elongated in mESC-CM (Figure 5.8I,L). Positive staining and some alignment was also 
observed on 10 mg/ml and 15 mg/ml gels (Figure 5.8C,F); however, the majority of the 
10mg/ml fibrin gel had degraded by day 6, and cells began to migrate to the tissue culture 
plastic (Figure 5.8C). 
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5.4.  DISCUSSION 
In this study, we examined the potential of PEGylated fibrin gels as a matrix for 
the retention of cardiomyocytes.  Previously, we reported that PEGylated fibrin gels 
promote revascularization and decrease fibrosis following myocardial infarction when 
seeded with mesenchymal stem cells (G. Zhang, Hu, Braunlin, Suggs, & Zhang, 2008).  
We observed that three-dimensional culture of HL-1 cardiomyocytes promotes the 
formation of cardiosphere-like aggregates, which while continuing to express cardiac-
specific markers and viability, appear to inhibit the functional, contractile phenotype.  
Alternatively, we found that contractility could be maintained when cells were cultured 
on layers of PEGylated fibrin, and that the rate of cardiomyocyte contraction was 
increased on more compliant gels.  In addition, contractile activity is maintained when 
cells are cultured in 2DL, suggesting that a layered PEGylated fibrin gel construct could 
potentially be used as an MI patch. 
Fibrin gels are commonly used in tissue engineering because of its 
biocompatibility and non-toxic byproducts during degradation (Breen, O'Brien, & Pandit, 
2009).  These gels can also be used as either an implanted patch or an injectable solution 
(Christman et al., 2004; Gerard et al., 2012; Johnson & Christman, 2012).  In general, the 
rate at which materials resorb in vivo depends partly on the ability of cells to remodel 
their environment and deposit ECM.  We observed that while HL-1 cardiomyocytes 
maintain sarcomeric α-actin and connexin 43 expression, they form cardiosphere-like 
aggregates within the scaffold regardless of the initial seeding density.  Recent studies 
have demonstrated that contractile activity of cardiomyocytes, specifically ESC-CM, is 
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best maintained in combination with cardiac fibroblasts, which can deposit ECM 
(Matsuura et al., 2011; Matsuura, Masuda, & Shimizu, 2014).  The importance of this co-
culture was suggested by our ESC-CM results, as the combination of cell types after EB 
dissociation and seeding onto gel layers resulted in nearly complete degradation of more 
compliant PEGylated fibrin gels by Day 5 (Figure 5.8C).  Our three-dimensional culture 
system may have the same requirement, and therefore future studies should examine the 
potential of cardiac fibroblast and cardiomyocyte co-cultures on 3D PEGylated fibrin 
remodeling in vitro and in vivo. 
As an alternative to true 3D culture, we examined the possibility of creating patch 
using layers of gels and cells for a sheet-like construct.  This cell sheet-like technology 
offers an alternative to traditional tissue engineered applications by providing a high-cell 
density construct that can be used as a cardiac patch.  These sheets have been produced 
using both temperature sensitive materials, in which confluent cell layers are detached 
from temperature-responsive polymer (poly(N-isopropylacrylamide)) coated dishes by 
changing incubation temperatures from 37oC to under 32oC (Bel et al., 2010; Sawa & 
Miyagawa, 2013; Shimizu et al., 2009).  Neonatal cardiomyocyte-sheets have also been 
fabricated on layers of fibrin gel, which can be easily detached from plates for 
myocardial patches (Itabashi et al., 2005; Patel & Zhang, 2013).  In this study, we 
examined the possibility of culturing HL-1 between layers of PEGylated fibrin gel, and 
observed that contractile activity and viability was maintained 24 hours after addition of a 
second gel layer.  While functional properties appear to be unaffected initially by 2DL 
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culture, future studies should examine long-term effects on proliferation and 
cardiomyocyte functionality. 
Material stiffness also plays an important role in maintaining the expression of 
cardiomyocyte functional markers.  To adjust gel stiffness we increased the initial 
concentration of fibrinogen in the PEGylated fibrin gels, and in doing so were able to 
generate materials with storage moduli ranging from 100 Pa to 1 kPa (Figure 5.1B). 
Initially, we hypothesized that contractile activity in both HL-1 and ESC-CM would be 
enhanced on stiffer gels, since hydrogels with elastic moduli of 9-14 kPa are optimal for 
ESC-CM maturity (Engler et al., 2008). In this study, HL-1 seeded on stiffer gels 
appeared to spread less compared to more compliant gels (Figure 5.4M,P).  HL-1 
cardiomyocytes are dependent on cell-cell contacts to propagate calcium signals and 
promote contractility (Claycomb et al., 1998).  The inability of HL-1 to become fully 
confluent on the 25 mg/ml gels may have been the reason for why the contractile 
frequency is reduced compared to 10 mg/ml gels, and not necessarily because of the 
elastic modulus.  Alternatively, in a report by Shapira-Schweitzer et al, ESC-CM 
expression of cardiomyocyte-specific markers, as well as increases in the number of 
contractile regions, were observed in PEGylated fibrin gels with elastic moduli of 23 ± 13 
Pa (Shapira-Schweitzer et al., 2009; Shapira-Schweitzer & Seliktar, 2007).  Therefore, 
our findings may be attributed to the nature of PEGylated fibrin gels and the ability of 
HL-1 to proliferate and spread on surfaces with more concentrated fibrinogen networks. 
Spontaneous contractile activity is a hallmark of ESC-CM and mature 
cardiomyocyte functionality (P.-Y. Wang, Yu, Lin, & Tsai, 2011; Xu, Police, Rao, & 
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Carpenter, 2002).  As ESC-CM mature, sarcomeres become more aligned, and beating 
frequency increases (Robertson, Tran, & George, 2013).  The rate largely depends on the 
study and how the cardiomyocytes are manipulated, such as by electrical or physical 
stimulation.  In this study, we observed HL-1 contractile rates ranging from 
approximately 0.9 seconds to 1.3 seconds depending on the fibrinogen concentration 
(Figure 5.5).  Interestingly, the contraction rate of HL-1 on 10 mg/ml gels was 
comparable to that observed on mechanically stimulated scaffolds (Mihic et al., 2014).  
While HL-1 contracted at a slower rate on other gel formulations, and in 2DL, the rate is 
still comparable to that observed on PEG-microsphere based scaffolds (Smith et al., 
2012) and gelatin sponges (Mihic et al., 2014).  Thus, while culturing HL-1 in 2DL may 
decrease contractile activity, the rate is still within the published range for the cells. 
Promoting ESC-CM maturity is an important precursor to their use in vivo for MI 
treatment.  As mentioned previously, contractile activity can be enhanced by co-culture 
when a percentage of cells are fibroblasts (van Spreeuwel et al., 2014; P.-Y. Wang et al., 
2011).  We generated ESC-CM from EBs using magnetically mediated strain, and 
following digestion obtained a cell population that was composed of approximately 50% 
cardiomyocytes.  When these cells were seeded on the PEGylated fibrin gels, the 
morphology was markedly different compared to HL-1 (Figure 5.8).  The cells became 
completely confluent on all of the gels, and the heterogeneity of this population resulted 
in partial digestion of the 10 mg/ml gel by Day 6 (Figure 5.8C).  Since contractile activity 
did not persist over the duration of the culture, the concentration of fibroblasts and other 
ECM-modifying cell types was likely too high to allow for ESC-CM maturation.  In the 
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future, the population of cells within the EB will need to be better assessed to control the 
ratio of ESC-CM and fibroblastic cell types.  By doing so, we can better understand the 
potential of PEGylated fibrin gels as patches, and confirm findings that compliant gels 
promote cardiomyocyte functionality.  
5.5.  CONCLUSIONS 
In this study, we observed that while 3D culture of a pure cardiomyocyte 
population in PEGylated fibrin gels inhibits functionality; however, this can be overcome 
with a layering approach.  HL-1 cultured within layers of hydrogel maintains sarcomeric 
α-actin alignment, regardless of the concentration of fibrinogen, and promotes contractile 
activity.  While ESC-CM appear to proliferate on the hydrogels, the concentration of 
non-cardiomyocytes in the EB inhibit cardiomyocyte maturation.  Consequently, while 
PEGylated fibrin gels have potential to be used as patches for MI repair, the phenotype of 
the starting cell population must be better controlled to optimize hydrogel formulation.  
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Table 5.1.  Volume of components used to fabricate PEGylated fibrin hydrogels for 2D, 
2DL, and 3D experiments.  
Gel Volume 
(μl) 
Fibrinogen 
volume (μl) 
SG-PEG-SG 
volume (μl) 
Medium/Cell 
volume (μl) 
Thrombin 
volume (μl) 
2D: 750 187.5 187.5 0 375 
2DL: 750 93.75 93.75 187.5 375 
3D: 500 62.5 62.5 125 250 
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Figure 5.1:  (A) Preparation of PEGylated fibrin gels. (B) Effect of fibrinogen 
concentration on PEGylated fibrin gel stiffness. 
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Figure 5.2:  HL-1 maintenance in 3D PEGylated fibrin gel matrices. (A) Formation of 
cardiosphere-like aggregates in matrices (arrows).  (B) Gross morphology of 
3D PEGylated fibrin gels by day 30. (C) Viability of HL-1 over 14 days in 
culture. (D) PCNA staining of Day 14 aggregates (1 M/ml).  (E) Fluo4 
cycling in aggregates over time.  (F) Expression of cardiomyocyte-specific 
markers at Day 15.  
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Figure 5.3.  Metabolic activity of HL-1 on 2D PEGylated fibrin gels. (A) Formulation of 
HL-1 seeded hydrogels. (B) Effect of fibrinogen concentration on HL-1 
metabolic activity over 14 days. 
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Figure 5.4.  Effect of fibrinogen concentration on HL-1 viability and cardiomyocyte-
specific marker expression.  (A,E,I,M) Phase contrast. (B,F,J,N) Calcein-
AM staining.  Green = live cells.  (C,G,K,O): Connexin 43 (Cx43) 
immunostaining. (D,H,L,P) Sarcomeric α-actin immunostaining.  Scale = 
100 μm. 
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Figure 5.5:  Fluo-4 calcium tracking of HL-1 on (A) 10 mg/ml PEGylated fibrin gels, (B) 
15 mg/ml PEGylated fibrin gels, (C) 20 mg/ml PEGylated fibrin gels and 
(D) 25 mg/ml PEGylated fibrin gels. (E) Rate of HL-1 contractile activity on 
PEGylated fibrin gels. *p<0.05, **p<0.001 
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Figure 5.6.  Effect of 2DL culture on HL-1 contractile activity and viability. (A) Cells 
remain completely confluent following addition of a second gel layer. (B) 
Cell viability after 24 hours. (C) Sarcomeric α-actin and (D) Connexin 43 
expression 24 hours after gel layer addition.  (E) Fluo-4 tracking of three 
ROIs after 24 hours. (E) Fluo-4 intensity in HL-1 on 10 mg/ml 2DL gels.  
(F) Comparison of calcium cycling duration in 10 mg/ml 2D gels, 2DL gels 
and 3D gels. *p<0.05.  Scale = 100 μm. 
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Figure 5.7.  Percentage of sarcomeric α-actin expressing cells from EBs with contracting 
areas. 
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Figure 5.8.  Effect of fibrinogen concentration on ESC-CM viability and sarcomeric α-
actin expression.  (A-C) 10mg/ml PEGylated fibrin gels. Dotted line 
demarcates interface between cells and degraded hydrogel.  (D-F) 15 mg/ml 
PEGylated fibrin gels, (G-H) 20 mg/ml PEGylated fibrin gels and (J-L) 25 
mg/ml PEGylated fibrin gels.  Scale = 100 μm. 
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CHAPTER SIX 
Conclusion and future directions 
6.1.  SUMMARY 
 Cell therapy has promise to be the gold standard for Myocardial Infarction (MI) 
treatment (Min et al., 2002).   Pluripotent stem cells (PSCs) are ideal candidates for this 
procedure due to their potential to differentiate into many different cell types.   To this 
end, there are specific scientific challenges that must be overcome to make their use in 
the clinic a reality: (1) determine more effective methods to direct differentiation into 
cardiomyocytes (Xu, Yi, & Chien, 2011), (2) improve upon current culture conditions to 
both maintain and promote maturation of stem cell derived cardiomyocytes (Nunes et al., 
2013; Robinson et al., 2005), and (3) improve upon current delivery methods to retain 
cardiomyocytes in the myocardium to enhance integration with the host tissue (Ye, Zhou, 
Cai, & Tan, 2011). 
 In this study, we investigated alternative methods to preferentially guide ESC 
differentiation towards cardiomyocytes using the EB model. Since there are diffusional 
limitations associated with EB culture, we hypothesized that delivery of pro-
cardiomyogenic proteins into the EB interior would increase exposure of ESCs within the 
EB to these proteins.  While these proteins could be immobilized to paramagnetic beads 
and incorporated within the EB, the beads alone appeared to play a significant role in 
increasing cardiomyogenesis.  By coupling Arginine-Glycine-Aspartic acid (RGD) 
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sequences to the beads, we can further guide differentiation by manipulating integrins 
using permanent magnets.  We observed that by combining this stimulation regimen with 
current biochemical stimulation protocols, we could enhance cardiomyogenesis in mouse 
EBs. 
Finally, we also investigated the potential of PEGylated fibrin gels to maintain 
and/or promote cardiomyocyte maturation.  As a model, we used HL-1 cardiomyocytes, 
which are derived from a mouse atrial tumor lineage.  HL-1 cardiomyocytes were 
cultured within and on top of fibrin hydrogels crosslinked with homobifunctional  
succinimidylglutarate polyethylene glycol (SG-PEG-SG).  Functional characteristics of 
cardiomyocytes, such as contractile activity and expression of cardiac-specific markers 
sarcomeric α-actin and connexin 43, were examined during the culture process.  As a 
comparison, ESC-CM derived from EBs were seeded on PEGylated fibrin gels with 
different fibrinogen concentrations and stiffness.  We observed that PEGylated fibrin gels 
do have the potential to be used as MI patches; however, the starting cell population is 
critical to maintain cardiomyocyte functionality. 
6.2.  CONCLUSION ON SHH AND BMP4 DELIVERY STUDIES 
Supplementation of Bone Morphogenetic Protein 4 (BMP4) to culture medium is 
currently the most effective protocol for deriving cardiomyocytes from mouse ESCs 
(Jamali, Karamboulas, Rogerson, & Skerjanc, 2001; Taha & Valojerdi, 2008).  Recent 
reports suggest that Sonic Hedgehog (SHH) can also induce cardiovascular fates from 
embryonic stem cells (Gianakopoulos & Skerjanc, 2009; Kusano et al., 2005).  In 
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Chapter 3, we attempted to overcome diffusional limitations of EB culture by 
immobilizing both BMP4 and SHH to paramagnetic beads and incorporating them into 
the EB during aggregation.  While there were early increases in most mesodermal 
markers, gene expression data indicated that differentiation was not directed towards any 
specific phenotype.  This is due possibly to decreased potency of tagged proteins 
compared to those without His- or MBP-tags.  Interestingly, cardiomyocyte 
differentiation was affected by the presence of beads that were not immobilized with 
proteins: the only condition that significantly increased contractile activity were the EBs 
with beads alone.  Using a focal adhesion protein array, integrin α1 was most changed in 
response to bead presence, suggesting an integrin-mediated interaction, which is 
ultimately increasing cardiomyogenesis.  
6.3.  CONCLUSION ON MAGNETIC ATTRACTION STUDIES 
The results from Chapter 3 suggested that mechanical interactions with 
paramagnetic beads could increase cardiomyogenesis by mechanotransduction.  In 
Chapter 4, we adapted the magnetic twisting cytometry (MTC) technique, which 
immobilizes RGD-sequences to paramagnetic beads and magnetizes the cells, to induce a 
stress on ESCs within the EBs.  We hypothesized that MTC, which was previously 
demonstrated to decrease pluripotency in mESCs (Min et al., 2002; Uda et al., 2011), 
could also guide differentiation.  We observed that magnetization could be used to apply 
stress to EBs at field strengths around 0.2 Tesla.   This stress activates integrin-mediated 
signaling pathways via protein kinase A (PKA) and ERK1/2.  In addition, this method 
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could be used to study the effects of mechanical stress on early EB time points: 
combining BMP4 with magnetically mediated strain increases cardiomyocyte 
differentiation over control groups when applied on Day 3.  This is evident by the 
significant increase in contractile areas and percentage of sarcomeric α-actin positive 
cells by Day 18. 
6.4.  CONCLUSION ON PEGYLATED FIBRIN GEL STUDIES FOR MAINTENANCE OF MATURE 
AND IMMATURE CARDIOMYOCYTES 
In Chapter 5, we investigated a tissue engineering approach to MI patch 
fabrication, in which PEGylated fibrin gels are seeded with cardiomyocytes.  HL-1 
cardiomyocytes are an ideal model because they are genotypically and phenotypically 
similar to mature cardiomyocytes (Claycomb et al., 1998; Xu et al., 2011).  Regardless of 
the initial seeding density, HL-1 cardiomyocytes seeded within 10 mg/ml PEGylated 
fibrin gels proliferate into cardiosphere-like aggregates.  These aggregates are viable, are 
proliferative and express both connexin 43 and sarcomeric α-actin; however, contractile 
activity is inhibited.  Cells seeded on top of PEGylated fibrin gels proliferate and 
maintain sarcomeric α-actin expression, although cells spread differently on the gels 
depending on the concentration.  Cardiomyocytes cultured on less concentrated and more 
compliant gels spread more, and as a result the rate of contractile activity is increased.  In 
contrast, cells that are cultured on more concentrated gels contract at a significantly lower 
rate.   
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Since contractile activity on 2D gels was maintained within the published range 
for HL-1, we attempted to create a 3D-like patch by layering cells in between PEGylated 
fibrin gels.  Similar approaches have been used with cell sheets to generate 3D constructs 
ex vivo (Leung & Sefton, 2010; Matsuura, Masuda, & Shimizu, 2014; Nunes et al., 2013; 
Robinson et al., 2005; Sakaguchi et al., 2013). To assess this possibility with our 
hydrogel technology, an additional gel layer was added to the top of confluent, contractile 
HL-1 cardiomyocytes.  After 24 hours, contractile activity and viability was maintained, 
albeit at a slightly decreased rate.   
In addition, we performed preliminary studies examining the behavior of ESC-
CM on the hydrogels.  ESC-CM were derived from EBs using the mechanical stimulation 
regimen described in Chapter 4.  After seeding onto gels, contractile activity was lost; 
however, only approximately 48% of the population was comprised of cardiomyocytes. 
6.5.  FUTURE DIRECTIONS 
The results described in this thesis demonstrate the potential of mechanical 
stimulation on directed differentiation of mESCs into cardiomyocytes.  A potential 
drawback to the work presented here is that experiments were performed in mouse 
pluripotent cells.  While this can serve as a model, to better elucidate their clinical use, 
understanding how these stimulation regimens direct differentiation of human ESCs and 
iPSCs will be important. 
In our protein delivery studies, we were unable to detect statistical differences in 
cell phenotype over the course of EB culture.  Possible reasons for this include (1) timing 
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of protein delivery and (2) the amount of immobilized protein delivered into the EB 
interior.  For the former, SHH exposure at early timepoints may not be adequate to direct 
differentiation into cardiomyocytes.  Pre-differentiation into mesendoderm may be 
necessary in order to guide cells towards cardiovascular fates.  In addition, the high 
variability made analysis of the SHH potential to guide differentiation difficult.  There is 
a possibility that Shh can direct differentiation; however, the potency of tagged-SHH is 
not sufficient for biological stimulation.  To verify that the lack of response is due to His-
tagged SHH potency alone, purmorphamine can be supplemented to the culture medium 
during ESC differentiation.  In addition, co-delivery of beads with different proteins may 
further enhance cardiomyogenesis in EBs. 
In Chapter 4, we observed that the magnetic field strength had a significant role in 
integrin-mediated signaling following the delivery of RGD-immobilized beads.  
Intermediate field strengths of approximately 0.2 T are sufficient to activate the 
MAPK/ERK signaling cascades.  While 0.128 T was not sufficient to activate 
mechanotransduction and 0.4 T increased cell death, a better understanding of the range 
of field strengths may be helpful to optimize the mechanical stimulation regimen.   
Another outstanding question from this study is exactly what the forces exerted on 
the cells within the EB are in response to magnetically mediated strain.  The most 
relevant model we found was that developed by Zborowski et al (1999), which 
approximates the force experienced by a cell in a quadripole field while bound to a 
magnetic particle (Ye et al., 2011; Zborowski, Sun, Moore, Stephen Williams, & 
Chalmers, 1999).  The EB microenvironment is more complex than this model can 
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account for, and consequently a more quantitative understanding of these forces would be 
beneficial. 
In addition, in Chapter 4 we focused on a narrow window of EB development: the 
effect of magnetically mediated strain was only examined between Days 1 and 3.  While 
we were primarily interested in the effects of stress at early timepoints, since this data is 
lacking from current stimulation protocols, examining the effects of magnetically 
mediated strain on later stages of EB development would also be interesting.  
Specifically, cardiomyogenesis may be even further stimulated when stress is applied on 
Day 4 or later.  A better understanding of the effects of magnetically mediated strain on 
lineage commitment will improve the potential of this method. 
Finally in Chapter 5, we examined the phenotypic and functional effects of 
PEGylated fibrin gels on cardiomyocyte maintenance and maturity.  The lack of 
contractile activity when HL-1 were cultured in 3D may be due to the inability of 
cardiomyocytes to modify their environment.  Cardiomyocytes account for only 20% of 
the entire cell population in the myocardium (Bergmann et al., 2009; Jamali et al., 2001; 
Taha & Valojerdi, 2008), and the addition of fibroblasts was observed to be critical to 
maintain contractile activity in cell sheets (Gianakopoulos & Skerjanc, 2005; Kusano et 
al., 2005; Matsuura et al., 2012).  Three-dimensional culture of cardiomyocytes in 
PEGylated fibrin gels may be improved by fine-tuning the proportion of cardiomyocytes 
and non-cardiomyocytes.  While a 50:50 ratio is too high (Figure 5.8), a lower percentage 
of cardiac fibroblasts may be sufficient for ECM remodeling and stimulation of 
contractile activity. 
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In this chapter, we also investigated the possibility of culturing cardiomyocytes in 
gel layers as an alternative to true 3D culture.  This strategy combines sheets of cells and 
materials, which the cells will eventually remodel. When the cardiomyocytes started 
displaying contractile activity (Day 4), an additional gel layer was added to the cells, and 
contractile activity and viability was maintained after 24 hours.  To further validate this 
method, the effects on long-term viability will also need to be assessed.  Since matrix 
remodeling is an important part of developing the 3D cardiac patch, optimization of the 
material properties and cell population may also be necessary.  For the former, producing 
nanostructured fibrinogen materials, such as by electrospinning (Frisman, Seliktar, & 
Bianco-Peled, 2011; H. Hosseinkhani, Hosseinkhani, Hattori, Matsuoka, & Kawaguchi, 
2010; Massumi et al., 2011), can minimize material thickness while providing the surface 
topography that is ideal for cardiomyocytes.  In addition, matrix remodeling can also be 
improved by altering the concentration of cardiomyocytes and non-cardiomyocytes. 
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